<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US7899507 - Physiological monitor - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Physiological monitor"><meta name="DC.contributor" content="Ammar Al-Ali" scheme="inventor"><meta name="DC.contributor" content="Mohamed K. Diab" scheme="inventor"><meta name="DC.contributor" content="Massi E. Kiani" scheme="inventor"><meta name="DC.contributor" content="Robert James Kopotic" scheme="inventor"><meta name="DC.contributor" content="David Tobler" scheme="inventor"><meta name="DC.contributor" content="Masimo Corporation" scheme="assignee"><meta name="DC.date" content="2006-5-3" scheme="dateSubmitted"><meta name="DC.description" content="A patient monitor has multiple sensors adapted to attach to tissue sites of a living subject. The sensors generate sensor signals that are responsive to at least two wavelengths of optical radiation after attenuation by pulsatile blood within the tissue sites. Multiple data channels and associated quality parameters are derived from the sensor signals. A processor is configured to operate on the channels according to the quality parameters so as to provide a robust oxygen status measurement."><meta name="DC.date" content="2011-3-1" scheme="issued"><meta name="DC.relation" content="US:3704706" scheme="references"><meta name="DC.relation" content="US:3847483" scheme="references"><meta name="DC.relation" content="US:4109643" scheme="references"><meta name="DC.relation" content="US:4653498" scheme="references"><meta name="DC.relation" content="US:4854699" scheme="references"><meta name="DC.relation" content="US:4869253" scheme="references"><meta name="DC.relation" content="US:4911167" scheme="references"><meta name="DC.relation" content="US:4927264" scheme="references"><meta name="DC.relation" content="US:4960128" scheme="references"><meta name="DC.relation" content="US:4964408" scheme="references"><meta name="DC.relation" content="US:5020516" scheme="references"><meta name="DC.relation" content="US:5041187" scheme="references"><meta name="DC.relation" content="US:5069213" scheme="references"><meta name="DC.relation" content="US:5078136" scheme="references"><meta name="DC.relation" content="US:5163438" scheme="references"><meta name="DC.relation" content="US:5218962" scheme="references"><meta name="DC.relation" content="US:5251632" scheme="references"><meta name="DC.relation" content="US:5253645" scheme="references"><meta name="DC.relation" content="US:5273036" scheme="references"><meta name="DC.relation" content="US:5308919" scheme="references"><meta name="DC.relation" content="US:5337744" scheme="references"><meta name="DC.relation" content="US:5385144" scheme="references"><meta name="DC.relation" content="US:5396893" scheme="references"><meta name="DC.relation" content="US:5431170" scheme="references"><meta name="DC.relation" content="US:5452717" scheme="references"><meta name="DC.relation" content="US:5482036" scheme="references"><meta name="DC.relation" content="US:5490505" scheme="references"><meta name="DC.relation" content="US:5494043" scheme="references"><meta name="DC.relation" content="US:5522388" scheme="references"><meta name="DC.relation" content="US:5533511" scheme="references"><meta name="DC.relation" content="US:5542421" scheme="references"><meta name="DC.relation" content="US:5562002" scheme="references"><meta name="DC.relation" content="US:5575284" scheme="references"><meta name="DC.relation" content="US:5590649" scheme="references"><meta name="DC.relation" content="US:5602924" scheme="references"><meta name="DC.relation" content="US:5632272" scheme="references"><meta name="DC.relation" content="US:5638816" scheme="references"><meta name="DC.relation" content="US:5638818" scheme="references"><meta name="DC.relation" content="US:5645440" scheme="references"><meta name="DC.relation" content="US:5647359" scheme="references"><meta name="DC.relation" content="US:5682877" scheme="references"><meta name="DC.relation" content="US:5685299" scheme="references"><meta name="DC.relation" content="US:5743261" scheme="references"><meta name="DC.relation" content="US:5743262" scheme="references"><meta name="DC.relation" content="US:5743857" scheme="references"><meta name="DC.relation" content="US:5758644" scheme="references"><meta name="DC.relation" content="US:5760910" scheme="references"><meta name="DC.relation" content="US:5769785" scheme="references"><meta name="DC.relation" content="US:5782757" scheme="references"><meta name="DC.relation" content="US:5785659" scheme="references"><meta name="DC.relation" content="US:5791347" scheme="references"><meta name="DC.relation" content="US:5810734" scheme="references"><meta name="DC.relation" content="US:5823950" scheme="references"><meta name="DC.relation" content="US:5827181" scheme="references"><meta name="DC.relation" content="US:5830131" scheme="references"><meta name="DC.relation" content="US:5830135" scheme="references"><meta name="DC.relation" content="US:5833618" scheme="references"><meta name="DC.relation" content="US:5846190" scheme="references"><meta name="DC.relation" content="US:5860919" scheme="references"><meta name="DC.relation" content="US:5890929" scheme="references"><meta name="DC.relation" content="US:5904654" scheme="references"><meta name="DC.relation" content="US:5919134" scheme="references"><meta name="DC.relation" content="US:5934925" scheme="references"><meta name="DC.relation" content="US:5940182" scheme="references"><meta name="DC.relation" content="US:5954053" scheme="references"><meta name="DC.relation" content="US:5995855" scheme="references"><meta name="DC.relation" content="US:5997343" scheme="references"><meta name="DC.relation" content="US:6002952" scheme="references"><meta name="DC.relation" content="US:6011986" scheme="references"><meta name="DC.relation" content="US:6027452" scheme="references"><meta name="DC.relation" content="US:6036642" scheme="references"><meta name="DC.relation" content="US:6045509" scheme="references"><meta name="DC.relation" content="US:6067462" scheme="references"><meta name="DC.relation" content="US:6081735" scheme="references"><meta name="DC.relation" content="US:6088607" scheme="references"><meta name="DC.relation" content="US:6094592" scheme="references"><meta name="DC.relation" content="US:6110522" scheme="references"><meta name="DC.relation" content="US:6122535" scheme="references"><meta name="DC.relation" content="US:6144868" scheme="references"><meta name="DC.relation" content="US:6151516" scheme="references"><meta name="DC.relation" content="US:6152754" scheme="references"><meta name="DC.relation" content="US:6157850" scheme="references"><meta name="DC.relation" content="US:6165005" scheme="references"><meta name="DC.relation" content="US:6184521" scheme="references"><meta name="DC.relation" content="US:6206830" scheme="references"><meta name="DC.relation" content="US:6229856" scheme="references"><meta name="DC.relation" content="US:6236872" scheme="references"><meta name="DC.relation" content="US:6256523" scheme="references"><meta name="DC.relation" content="US:6263222" scheme="references"><meta name="DC.relation" content="US:6278522" scheme="references"><meta name="DC.relation" content="US:6280213" scheme="references"><meta name="DC.relation" content="US:6285896" scheme="references"><meta name="DC.relation" content="US:6321100" scheme="references"><meta name="DC.relation" content="US:6334065" scheme="references"><meta name="DC.relation" content="US:6343224" scheme="references"><meta name="DC.relation" content="US:6349228" scheme="references"><meta name="DC.relation" content="US:D353195" scheme="references"><meta name="DC.relation" content="US:D353196" scheme="references"><meta name="DC.relation" content="US:D361840" scheme="references"><meta name="DC.relation" content="US:D362063" scheme="references"><meta name="DC.relation" content="US:D363120" scheme="references"><meta name="DC.relation" content="US:D393830" scheme="references"><meta name="citation_reference" content="Bartlett, &quot;Oxygen Kinetics&quot;, Critical Care Physiology, 13th Ed., pp. 1-23."><meta name="citation_reference" content="Drummond, Willa H., &quot;Ductus Arteriosus&quot;, Cardiovascular Disease in the Neonate, pp. 760-771."><meta name="citation_reference" content="Dudell, Glode, et al., &quot;What Constitutes Adequate Oxygenation?&quot; Pediatrics, Jan. 1990, pp. 39-41."><meta name="citation_reference" content="Mallinckrodt inc. v. Masimo Corp., 2004 U.S. Dist. Lexis 28518 (C.D. Cal. Jul. 12, 2004)."><meta name="citation_reference" content="Mallinckrodt, Inc. v. Masimo Corp., 147 Fed. Appx. 158, 2005 WL 2139867 (Fed. Cir. 2005)."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-000080(JJF)) Complaint for Patent Infringement dated Feb. 3, 2009, pp. 1-13."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Defendant/Counterclaim-Plaintiff Philips Electronics North America Corporation Answer to Masimo&#39;s Counterclaims dated Aug. 3, 2009, pp. 1-23."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Defendants&#39; Answer and Philips Electronics North America Corporation&#39;s Amended Counterclaims to Masimo&#39;s First Amended Complaint, dated Apr. 21, 2010, pp. 1-62."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Defendants&#39; Answer and Philips Electronics North America Corporation&#39;s Counterclaims to Masimo&#39;s First Amended Complaint dated Jun. 15, 2009, pp. 1-65."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) First Amended Complaint for Patent Infringement dated May 12, 2009, pp. 1-16."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Masimo&#39;s Answer to Philips&#39; Amended Counterclaims, dated May 10, 2010, pp. 1-76."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Masimo&#39;s Answer to Philips&#39; Counterclaims dated Jul. 9, 2009, pp. 1-68."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Philips Electronics North America Corporation&#39;s Answer to Masimo&#39;s Amended Counterclaims (D.I. 102) dated May 27, 2010, pp. 1-24."><meta name="citation_reference" content="Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Philips North America Corporation and Philips Medizin Systeme Boblingen GmbH&#39;s Seventh Supplemental Objections and Responses to Masimo Corporation&#39;s First Set of Interrogatories (Nos. 1-8) dated Jun. 30, 2010, pp. 1-40 (redacted)."><meta name="citation_reference" content="Murray, Willie et al., &quot;The Peripheral Pulse Wave: Information Overlooked&quot;, Journal of Clinical Monitoring, vol. 12, pp. 365-377, Sep. 1996."><meta name="citation_reference" content="Neuhof, H. et al., &quot;Simultaneous Continuous Measurement of Arterial and Mixed Venous Partial O2 Saturation&quot;, The Oxygen Status of Arterial Blood, Zander, Mertzlufft (eds.), pp. 273-278 (Karger, Basel 1991)."><meta name="citation_reference" content="Scharf, University of South Florida Department of Anesthesiology, &quot;Pulse Oximetry Through Spectral Analysis,&quot; pp. 227-235."><meta name="citation_reference" content="Scharf, USF Department of Anesthesiology, USF Department of Electrical Engineering, Optimization of Portable Pulse Oximetry Through Fourier Analysis, pp. 233-235."><meta name="citation_reference" content="Steinke, John M., Comparison of Mie Theory and the Light Scattering of Red Blood Cells:, Applied Optics, vol. 27, No. 19, Oct. 1, 1998, pp. 4027-4033."><meta name="citation_reference" content="Vjayakumar, E., et al., &quot;Pulse Oximetry in Infants of &lt;1500 gm Birth Weight on Supplemental Oxygen: A national Survey&quot;, Journal of Perinatology, vol. 17, No. 5, 1997, pp. 341-345."><meta name="citation_reference" content="Weis, Carla M. et al., &quot;Oxygen Therapy&quot;, Chapt. 46, Pulmonary Disease in the Neonate, pp. 538-545."><meta name="citation_reference" content="White, Katherine, &quot;Completing the Hemodynamic Picture: Svox&quot;, Heart &amp; Lung, May 1985, vol. 14, No. 3."><meta name="citation_reference" content="Wolf, Martin, et al., &quot;Continuous Noninvasive Measurement of Cerebral Arterial and Venous Oxygen Saturation at the Bedside in Mechanically Ventilated Noenates\&quot;, Critl Care Med, 1997, vol. 25, No. 9, pp. 1579-1582."><meta name="citation_patent_number" content="US:7899507"><meta name="citation_patent_application_number" content="US:11/417,545"><link rel="canonical" href="http://www.google.com/patents/US7899507"/><meta property="og:url" content="http://www.google.com/patents/US7899507"/><meta name="title" content="Patent US7899507 - Physiological monitor"/><meta name="description" content="A patient monitor has multiple sensors adapted to attach to tissue sites of a living subject. The sensors generate sensor signals that are responsive to at least two wavelengths of optical radiation after attenuation by pulsatile blood within the tissue sites. Multiple data channels and associated quality parameters are derived from the sensor signals. A processor is configured to operate on the channels according to the quality parameters so as to provide a robust oxygen status measurement."/><meta property="og:title" content="Patent US7899507 - Physiological monitor"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("qkjsU-qzIcnxgwTj6YGoBg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("BRA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("qkjsU-qzIcnxgwTj6YGoBg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("BRA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us7899507?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US7899507"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=ZqovBwABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS7899507&amp;usg=AFQjCNHpXxgLs2KAMlydxxs24aE0de2ltg" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US7899507.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US7899507.pdf"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20060270920"></a><a class="appbar-application-grant-link" data-selected="true" data-label="Grant" href="/patents/US7899507"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US7899507" style="display:none"><span itemprop="description">A patient monitor has multiple sensors adapted to attach to tissue sites of a living subject. The sensors generate sensor signals that are responsive to at least two wavelengths of optical radiation after attenuation by pulsatile blood within the tissue sites. Multiple data channels and associated quality...</span><span itemprop="url">http://www.google.com/patents/US7899507?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US7899507 - Physiological monitor</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US7899507 - Physiological monitor" title="Patent US7899507 - Physiological monitor"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US7899507 B2</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 11/417,545</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Mar 1, 2011</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">May 3, 2006</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jun 3, 1998</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2333062A1">CA2333062A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1082050A1">EP1082050A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP1082050B1">EP1082050B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP2319398A1">EP2319398A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6334065">US6334065</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6714804">US6714804</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6898452">US6898452</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7761128">US7761128</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7891355">US7891355</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7894868">US7894868</a>, </span><span class="patent-bibdata-value"><a href="/patents/US8255028">US8255028</a>, </span><span class="patent-bibdata-value"><a href="/patents/US8364223">US8364223</a>, </span><span class="patent-bibdata-value"><a href="/patents/US8721541">US8721541</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20020082488">US20020082488</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20040059209">US20040059209</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20050197551">US20050197551</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060258923">US20060258923</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060258924">US20060258924</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060258925">US20060258925</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060270920">US20060270920</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060281983">US20060281983</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20130197330">US20130197330</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1999062399A1">WO1999062399A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1999062399A9">WO1999062399A9</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">11417545, </span><span class="patent-bibdata-value">417545, </span><span class="patent-bibdata-value">US 7899507 B2, </span><span class="patent-bibdata-value">US 7899507B2, </span><span class="patent-bibdata-value">US-B2-7899507, </span><span class="patent-bibdata-value">US7899507 B2, </span><span class="patent-bibdata-value">US7899507B2</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Ammar+Al-Ali%22">Ammar Al-Ali</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Mohamed+K.+Diab%22">Mohamed K. Diab</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Massi+E.+Kiani%22">Massi E. Kiani</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Robert+James+Kopotic%22">Robert James Kopotic</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22David+Tobler%22">David Tobler</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Masimo+Corporation%22">Masimo Corporation</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US7899507.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7899507.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7899507.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (102),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (23),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (2),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (30),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (4)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/7899507&usg=AFQjCNFdCAPIauEPKNbsFECviiYQt6owLQ">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D7899507&usg=AFQjCNH8GG-1atYAaoCtuoqOpS-HvRwcRA">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D7899507B2%26KC%3DB2%26FT%3DD&usg=AFQjCNEQlITZEcBIc5ToxT457-08Oe-tdw">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT100995988" lang="EN" load-source="patent-office">Physiological monitor</invention-title></span><br><span class="patent-number">US 7899507 B2</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA83261756" lang="EN" load-source="patent-office"> <div num="p-0001" class="abstract">A patient monitor has multiple sensors adapted to attach to tissue sites of a living subject. The sensors generate sensor signals that are responsive to at least two wavelengths of optical radiation after attenuation by pulsatile blood within the tissue sites. Multiple data channels and associated quality parameters are derived from the sensor signals. A processor is configured to operate on the channels according to the quality parameters so as to provide a robust oxygen status measurement.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(26)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00000.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00000.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00001.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00001.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00002.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00002.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00003.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00003.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00004.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00004.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00005.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00005.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00006.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00006.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00007.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00007.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00008.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00008.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00009.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00009.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00010.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00010.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00011.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00011.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00012.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00012.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00013.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00013.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00014.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00014.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00015.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00015.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00016.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00016.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00017.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00017.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00018.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00018.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00019.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00019.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00020.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00020.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00021.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00021.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00022.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00022.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00023.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00023.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00024.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00024.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US7899507B2/US07899507-20110301-D00025.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US7899507B2/US07899507-20110301-D00025.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(11)</span></span></div><div class="patent-text"><div mxw-id="PCLM35057523" lang="EN" load-source="patent-office" class="claims">
    <div class="claim"> <div id="CLM-00001" num="00001" class="claim">
      <div class="claim-text">1. A patient monitoring method comprising:
<div class="claim-text">inputting sensor signals from at least two physiological sensors of a physiological monitor, the physiological sensors attached to tissue sites comprising two or more of at least a portion the left arm, right arm, left leg, right leg, head, and neck of a patient;</div>
<div class="claim-text">generating data channels corresponding to each of the tissue sites based on the sensor signals;</div>
<div class="claim-text">calculating signal quality for each of the data channels using one or more processors of the physiological monitor; and</div>
<div class="claim-text">outputting a first oxygen status parameter or plethysmograph derived from at least one of the data channels based upon a comparison of the calculated signal qualities.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00002" num="00002" class="claim">
      <div class="claim-text">2. The patient monitoring method according to <claim-ref idref="CLM-00001">claim 1</claim-ref> further comprising, using the one or more processors:
<div class="claim-text">selecting a low noise one of the data channels based upon the calculated signal qualities; and</div>
<div class="claim-text">deriving the oxygen status parameter from the selected data channel during a particular time period.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00003" num="00003" class="claim">
      <div class="claim-text">3. The patient monitoring method according to <claim-ref idref="CLM-00001">claim 1</claim-ref> further comprising, using the one or more processors, deriving the oxygen status parameter from a combination of noisy data channels according to the signal quality calculations.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00004" num="00004" class="claim">
      <div class="claim-text">4. The patient monitoring method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the tissue sites include a right hand and a left hand of the patient.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00005" num="00005" class="claim">
      <div class="claim-text">5. The patient monitoring method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the tissue sites include a hand of the patient and a foot of the patient.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00006" num="00006" class="claim">
      <div class="claim-text">6. The patient monitoring method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the tissue sites include an upper body extremity and a lower body extremity.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00007" num="00007" class="claim">
      <div class="claim-text">7. The patient monitoring method of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the first oxygen status parameter or plethysmograph is derived from one of the data channels, the method further comprising, using the one or more processors:
<div class="claim-text">comparing the first oxygen status parameter or plethysmograph with a second oxygen status parameter or plethysmograph derived from another of the data channels; and</div>
<div class="claim-text">determining the presence of an abnormal health condition of the patient based upon the comparison.</div>
</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00008" num="00008" class="claim">
      <div class="claim-text">8. The patient monitoring method of <claim-ref idref="CLM-00007">claim 7</claim-ref>, wherein the abnormal health condition comprises a heart abnormality.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00009" num="00009" class="claim">
      <div class="claim-text">9. The patient monitoring method of <claim-ref idref="CLM-00007">claim 7</claim-ref>, wherein the first and second oxygen status parameters or plethysmographs comprise first and second oxygen saturation values and the comparing comprises calculating a difference between the first and the second oxygen saturation values.</div>
    </div>
    </div> <div class="claim-dependent"> <div id="CLM-00010" num="00010" class="claim">
      <div class="claim-text">10. The patient monitoring method of <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein determining comprises determining the presence of the abnormal health condition where the difference between the first and second oxygen saturation values is greater than a threshold amount.</div>
    </div>
    </div> <div class="claim"> <div id="CLM-00011" num="00011" class="claim">
      <div class="claim-text">11. A patient monitoring method, comprising:
<div class="claim-text">inputting sensor signals from at least two physiological sensors of a physiological monitor, the physiological sensors attached to tissue sites of a plurality of appendages of a patient;</div>
<div class="claim-text">generating data channels corresponding to each of the tissue sites based on the sensor signals;</div>
<div class="claim-text">calculating signal quality for each of the data channels using one or more processors of the physiological monitor;</div>
<div class="claim-text">outputting a first oxygen status parameter or plethysmograph derived from at least one of the data channels based upon a comparison of the calculated signal qualities;</div>
<div class="claim-text">ignoring a noisy one of the data channels based upon the calculated signal qualities; and</div>
<div class="claim-text">deriving the oxygen status parameter from one or more of the remaining data channels during a particular time period. </div>
</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES40901597" lang="EN" load-source="patent-office" class="description">
    <heading>CROSS-REFERENCE TO RELATED APPLICATIONS</heading> <p num="p-0002">This application is a continuation of U.S. application Ser. No. 11/104,720, filed Apr. 13, 2005, which is a continuation of U.S. application Ser. No. 10/668,487, filed Sep. 22, 2003, now U.S. Pat. No. 6,898,452, which is a continuation of U.S. application Ser. No. 10/026,013, filed Dec. 21, 2001, now U.S. Pat. No. 6,714,804, which is a continuation of U.S. application Ser. No. 09/323,176, filed May 27, 1999, now U.S. Pat. No. 6,334,065, which claims priority from U.S. Provisional No. 60/087,802, filed Jun. 3, 1998.</p>
    <heading>BACKGROUND</heading> <p num="p-0003">The measurement of oxygen delivery to the body and the corresponding oxygen consumption by its organs and tissues is vitally important to medical practitioners in the diagnosis and treatment of various medical conditions. Oxygen delivery, the transport of oxygen from the environment to organs and tissues, depends on the orchestration of several interrelated physiologic systems. Oxygen uptake is determined by the amount of oxygen entering the lung and the adequacy of gas exchange within the lung. This gas exchange is determined by the diffusion of oxygen from the alveolar space to the blood of the pulmonary capillaries. Oxygen is subsequently transported to all organs and tissues by blood circulation maintained by the action of the heart. The availability of oxygen to the organs and tissues is determined both by cardiac output and by the oxygen content in the blood. Oxygen content, in turn, is affected by the concentration of available hemoglobin and hemoglobin oxygen saturation. Oxygen consumption is related to oxygen delivery according to Fick's axiom, which states that oxygen consumption in the peripheral tissues is equal to oxygen delivery via the airway.</p>
    <p num="p-0004">Oxygen delivery and oxygen consumption can be estimated from a number of measurable parameters. Because of the diagnostic impracticalities of measuring oxygen uptake and cardiac output, oxygen delivery is typically assessed from the oxygen status of arterial blood alone, such as arterial oxygen partial pressure, P<sub>a</sub>O<sub>2</sub>, and arterial oxygen saturation, S<sub>a</sub>O<sub>2</sub>. P<sub>a</sub>O<sub>2 </sub>represents the relatively small amount of oxygen dissolved in the blood plasma. S<sub>a</sub>O<sub>2 </sub>represents the much larger amount of oxygen chemically bound to the blood hemoglobin. Oxygen consumption is typically assessed from the oxygen status of mixed venous blood, i.e. the oxygen saturation of blood from the pulmonary artery, S<sub>v</sub>O<sub>2</sub>, which is used to estimate the O<sub>2 </sub>concentration of blood returning from all tissues and organs of the body. These parameters can be measured by both invasive and non-invasive techniques, except S<sub>v</sub>O<sub>2</sub>, which requires an invasive measurement.</p>
    <p num="p-0005">Invasive techniques include blood gas analysis using the in vitro measurement of extracted arterial or venous blood, drawn with a syringe and needle or an intervascular catheter. Arterial blood is commonly obtained by puncturing the brachial, radial or femoral artery. Venous blood can be obtained from an arm vein, but such a sample reflects only local conditions. To obtain mixed venous blood, which represents the composite of all venous blood, a long catheter is typically passed through the right heart and into the main pulmonary artery from a peripheral vein. Extracted blood gas analysis utilizes blood gas machines or oximeters. A blood gas machine measures the partial pressure of oxygen, PO<sub>2</sub>, using a “Clark electrode” that detects the current generated by oxygen diffusing to a sealed platinum electrode across a gas permeable membrane. An oximeter measures the oxygen saturation, SO<sub>2</sub>, of oxygenated and deoxygenated hemoglobin using spectrophotometry techniques that detect the differential absorption of particular wavelengths of light by these blood components.</p>
    <p num="p-0006">Invasive monitoring also includes the in vivo monitoring of blood gas via a catheter sensor inserted into an artery or vein. Miniaturization of the Clark electrode allows placement of the electrode in a catheter for continuous measurement of PO<sub>2</sub>. A fiber optic equipped catheter attached to an external oximeter allows continuous measurement of oxygen saturation. Because of risks inherent in catheterization and the promotion of blood coagulation by certain sensors, these techniques are typically only used when vitally indicated.</p>
    <p num="p-0007">Non-invasive techniques include pulse oximetry, which allows the continuous in vivo measurement of arterial oxygen saturation and pulse rate in conjunction with the generation of a photoplethsymograph waveform. Measurements rely on sensors which are typically placed on the fingertip of an adult or the foot of an infant. Non-invasive techniques also include transcutaneous monitoring of PO<sub>2</sub>, accomplished with the placement of a heated Clark electrode against the skin surface. These non-invasive oxygen status measurement techniques are described in further detail below.</p>
    <heading>SUMMARY</heading> <p num="p-0008">Prior art invasive oxygen assessment techniques are inherently limited. Specifically, in vitro measurements, that is, blood extraction and subsequent analysis in a blood gas machine or an oximeter, are non-simultaneous and non-continuous. Further, in vivo measurements through catheterization are not casual procedures and are to be particularly avoided with respect to neonates. Prior art noninvasive techniques are also limited. In particular, conventional pulse oximeters are restricted to measurement of arterial oxygen saturation at a single patient site. Also, transcutaneous monitoring is similarly restricted to the measurement of an estimate of arterial partial pressure at a single patient site, among other limitations discussed further below.</p>
    <p num="p-0009">The stereo pulse oximeter according to the present invention overcomes many of the limitations of prior art oxygen status measurements. The word “stereo” comes from the Greek word stereos, which means “solid” or three-dimensional. For example, stereophonic systems use two or more channels to more accurately reproduce sound. The stereo pulse oximeter is similarly multi-dimensional, providing simultaneous, continuous, multiple-site and multiple-parameter oxygen status and plethysmograph (photoplethysmograph) measurements. The stereo pulse oximeter provides a benefit in terms of cost and patient comfort and safety over invasive oxygen status estimation techniques. The multi-dimensional aspects of this invention further provide oxygen status and plethysmograph measurements not available from current noninvasive techniques. In addition, the stereo pulse oximeter allows the isolation of noise artifacts, providing more accurate oxygen status and plethysmograph measurements than available from conventional techniques. The result is improved patient outcome based on a more accurate patient assessment and better management of patient care.</p>
    <p num="p-0010">In one aspect of the stereo pulse oximeter, data from a single sensor is processed to advantageously provide continuous and simultaneous multiple-parameter oxygen status and plethysmograph measurements from a particular tissue site. This is in contrast to a conventional pulse oximeter that provides only arterial oxygen saturation data from a tissue site. In particular a physiological monitor comprises a sensor interface and a signal processor. The sensor interface is in communication with a peripheral tissue site and has an output responsive to light transmitted through the site. The signal processor is in communication with the sensor interface output and provides a plurality of parameters corresponding to the oxygen status of the site, the plethysmograph features of the site or both. The parameters comprise a first value and a second value related to the peripheral tissue site. In one embodiment, the first value is an arterial oxygen saturation and the second value is a venous oxygen saturation. In this embodiment, another parameter provided may be the difference between arterial oxygen saturation and venous oxygen saturation at the tissue site. The venous oxygen saturation is derived from an active pulse generated at the site. The signal processor output may further comprise a scattering indicator corresponding to the site, and the sensor interface may further comprise a pulser drive, which is responsive to the scattering indicator to control the amplitude of the active pulse. One of the parameter values may also be an indication of perfusion.</p>
    <p num="p-0011">In another aspect of the stereo pulse oximeter, data from multiple sensors is processed to advantageously provide continuous and simultaneous oxygen status measurements from several patient tissue sites. This is in contrast to a conventional pulse oximeter that processes data from a single sensor to provide oxygen status at a single tissue site. In particular, a physiological monitor comprises a plurality of sensor interfaces each in communications with one of a plurality of peripheral tissue sites. Each of the sensor interfaces has one of a plurality of outputs responsive to light transmitted through a corresponding one of the tissue sites. A signal processor is in communication with the sensor interface outputs and has a processor output comprising a plurality of parameters corresponding to the oxygen status of the sites, the plethysmograph features of the sites or both. The parameters may comprise a first value relating to a first of the peripheral tissue sites and a second value relating to a second of the peripheral tissue sites. In one embodiment, the first value and the second value are arterial oxygen saturations. In another embodiment, the first value and the second value are plethysmograph waveform phases. The physiological monitor may further comprise a sensor attachable to each of the tissue sites. This sensor comprises a plurality of emitters and a plurality of detectors, where at least one of the emitters and at least one of the detectors is associated with each of the tissue sites. The sensor also comprises a connector in communications with the sensor interfaces. A plurality of signal paths are attached between the emitters and the detectors at one end of the sensor and the connector at the other end of the sensor.</p>
    <p num="p-0012">In yet another aspect of the stereo pulse oximeter, data from multiple sensors is processed to advantageously provide a continuous and simultaneous comparison of the oxygen status between several tissue sites. A conventional oximeter, limited to measurements at a single tissue site, cannot provide these cross-site comparisons. In particular a physiological monitoring method comprises the steps of deriving a reference parameter and a test parameter from oxygen status measured from at least one of a plurality of peripheral tissue sites and comparing that reference parameter to the test parameter so as to determine a patient condition. The reference parameter may be a first oxygen saturation value and the test parameter a second oxygen saturation value. In that case, the comparing step computes a delta oxygen saturation value equal to the arithmetic difference between the first oxygen saturation value and the second oxygen saturation value. In one embodiment, the reference parameter is an arterial oxygen saturation measured at a particular one the tissue sites and the test parameter is a venous oxygen saturation measured at that particular site. In another embodiment, the reference parameter is a first arterial oxygen saturation value at a first of the tissue sites, the test parameter is a second arterial oxygen saturation value at a second of the tissue sites. In yet another embodiment, the reference parameter is a plethysmograph feature measured at a first of the sites, the test parameter is a plethysmograph feature measured at a second of the sites and the monitoring method comparison step determines the phase difference between plethysmographs at the first site and the second site. In a further embodiment, the comparing step determines a relative amount of damping between plethysmographs at the first site and the second site. The multi-dimensional features of these embodiments of the stereo pulse oximeter can be advantageously applied to the diagnosis and managed medical treatment of various medical conditions. Particularly advantageous applications of stereo pulse oximetry include oxygen titration during oxygen therapy, nitric oxide titration during therapy for persistent pulmonary hypertension in neonates (PPHN), detection of a patent ductus arteriosis (PDA), and detection of an aortic coarctation.</p>
    <description-of-drawings> <heading>BRIEF DESCRIPTION OF THE DRAWINGS</heading> <p num="p-0013">The present invention will be described in detail below in connection with the following drawing figures in which:</p>
      <p num="p-0014"> <figref idrefs="DRAWINGS">FIG. 1A</figref> is a top-level block diagram of a stereo pulse oximeter according to the present invention;</p>
      <p num="p-0015"> <figref idrefs="DRAWINGS">FIG. 1B</figref> shows a single-sensor alternative embodiment to <figref idrefs="DRAWINGS">FIG. 1A</figref>;</p>
      <p num="p-0016"> <figref idrefs="DRAWINGS">FIG. 2</figref> is a block diagram of the stereo pulse oximeter sensor interface;</p>
      <p num="p-0017"> <figref idrefs="DRAWINGS">FIG. 3</figref> is a graph illustrating the absorption of red and infrared wavelengths by both oxygenated and deoxygenated hemoglobin;</p>
      <p num="p-0018"> <figref idrefs="DRAWINGS">FIG. 4</figref> is a graph showing the empirical relationship between the “red over infrared” ratio and arterial oxygen saturation;</p>
      <p num="p-0019"> <figref idrefs="DRAWINGS">FIG. 5</figref> is a block diagram of the analog signal conditioning for the sensor interface;</p>
      <p num="p-0020"> <figref idrefs="DRAWINGS">FIG. 6</figref> is a functional block diagram of the stereo pulse oximeter signal processing;</p>
      <p num="p-0021"> <figref idrefs="DRAWINGS">FIG. 7</figref> is a functional block diagram of the front-end signal processing;</p>
      <p num="p-0022"> <figref idrefs="DRAWINGS">FIG. 8</figref> is a graph depicting the frequency spectrum of an arterial intensity signal;</p>
      <p num="p-0023"> <figref idrefs="DRAWINGS">FIG. 9</figref> is a graph depicting the frequency spectrum of a combined arterial and venous intensity signal;</p>
      <p num="p-0024"> <figref idrefs="DRAWINGS">FIG. 10</figref> is a functional block diagram of the saturation calculation signal processing;</p>
      <p num="p-0025"> <figref idrefs="DRAWINGS">FIG. 11</figref> is a graph illustrating a plethysmograph waveform;</p>
      <p num="p-0026"> <figref idrefs="DRAWINGS">FIG. 12</figref> is a graph illustrating the absorption contribution of various blood and tissue components;</p>
      <p num="p-0027"> <figref idrefs="DRAWINGS">FIG. 13</figref> is a graph illustrating an intensity “plethysmograph” pulse oximetry waveform;</p>
      <p num="p-0028"> <figref idrefs="DRAWINGS">FIG. 14</figref> is a functional block diagram of the plethysmograph feature extraction signal processing;</p>
      <p num="p-0029"> <figref idrefs="DRAWINGS">FIG. 15</figref> is a functional block diagram of the multiple parameter signal processing;</p>
      <p num="p-0030"> <figref idrefs="DRAWINGS">FIG. 16A</figref> is an illustration of a single-site stereo pulse oximeter display screen;</p>
      <p num="p-0031"> <figref idrefs="DRAWINGS">FIG. 16B</figref> is an illustration of a multi-site stereo pulse oximeter display screen;</p>
      <p num="p-0032"> <figref idrefs="DRAWINGS">FIG. 17A</figref> is a graph depicting a family of constant power curves for the electrical analog of constant oxygen consumption;</p>
      <p num="p-0033"> <figref idrefs="DRAWINGS">FIG. 17B</figref> is a graph depicting arterial and venous oxygen saturation versus fractional inspired oxygen;</p>
      <p num="p-0034"> <figref idrefs="DRAWINGS">FIG. 17C</figref> is a graph depicting arterial minus venous oxygen saturation versus fractional inspired oxygen;</p>
      <p num="p-0035"> <figref idrefs="DRAWINGS">FIG. 18</figref> is a three-dimensional graph depicting a delta oxygen saturation surface;</p>
      <p num="p-0036"> <figref idrefs="DRAWINGS">FIG. 19</figref> is an illustration of a neonatal heart depicting a pulmonary hypertension condition;</p>
      <p num="p-0037"> <figref idrefs="DRAWINGS">FIG. 20</figref> is an illustration of a fetal heart depicting the ductus arteriosis; and</p>
      <p num="p-0038"> <figref idrefs="DRAWINGS">FIG. 21</figref> is an illustration of a neonatal heart depicting a patent ductus arteriosis (PDA).</p>
    </description-of-drawings> <heading>DETAILED DESCRIPTION</heading> <p num="p-0039">Stereo Pulse Oximetry</p>
    <p num="p-0040"> <figref idrefs="DRAWINGS">FIG. 1A</figref> illustrates the multi-dimensional features of a stereo pulse oximeter <b>100</b> according to the present invention. Shown in <figref idrefs="DRAWINGS">FIG. 1A</figref> is an exemplary stereo pulse oximeter configuration in which a first sensor <b>110</b> is attached to a neonate's left hand, a second sensor <b>120</b> is attached to one of the neonate's feet, and a third sensor <b>130</b> is attached to the neonate's right hand. In general, these sensors are used to obtain oxygen status and photoplethysmograph measurements at peripheral sites, including a person's ears and face, such as the nose and regions of the mouth in addition to hands, feet and limbs, but not including internal sites such as internal organs and the brain.</p>
    <p num="p-0041">Each sensor <b>110</b>, <b>120</b>, <b>130</b> provides a stream of data through a corresponding sensor interface <b>114</b>, <b>124</b>, <b>134</b> to the digital signal processor (DSP) <b>150</b>. For example, the first sensor <b>110</b> is connected to an input <b>112</b> of the first sensor interface <b>114</b>, and the output <b>118</b> of the first sensor interface <b>114</b> is attached to a first data channel input <b>152</b> of the DSP <b>150</b>. Similarly, the second sensor <b>120</b> provides data to a second data channel input <b>154</b> and the third sensor <b>130</b> provides data to a third data channel input <b>158</b>.</p>
    <p num="p-0042"> <figref idrefs="DRAWINGS">FIG. 1B</figref> illustrates an alternative embodiment of the separate sensors <b>110</b>, <b>120</b>, <b>130</b> (<figref idrefs="DRAWINGS">FIG. 1A</figref>). A stereo sensor <b>140</b> has multiple branches <b>112</b>, <b>122</b>, <b>132</b> each terminating in a sensor portion <b>114</b>, <b>124</b>, <b>134</b>. Each sensor portion <b>114</b>, <b>124</b>, <b>134</b> has two light emitters and a light detector, as described below, and is attachable to a separate patient site. Thus, the stereo sensor <b>140</b> advantageously provides a single sensor device having multiple light emitters and multiple light detectors for attachment to multiple patient tissue sites. A combination of the stereo sensor <b>140</b> and a single patient cable <b>142</b> advantageously allows a single connection <b>144</b> at the stereo pulse oximeter <b>100</b> and a single connection <b>146</b> at the stereo sensor <b>140</b>.</p>
    <p num="p-0043">The DSP <b>150</b> can independently process each data channel input <b>152</b>, <b>154</b>, <b>158</b> and provide outputs <b>162</b> typical of pulse oximetry outputs, such as arterial oxygen saturation, Sp<sub>a</sub>O<sub>2</sub>, the associated plethysmograph waveform and the derived pulse rate. In contrast with a conventional pulse oximeter, however, these outputs <b>162</b> include simultaneous measurements at each of several patient tissue sites. That is, for the configuration of <figref idrefs="DRAWINGS">FIG. 1A</figref>, the stereo pulse oximeter <b>100</b> simultaneously displays Sp<sub>a</sub>O<sub>2 </sub>and an associated plethysmograph waveform for three tissue sites in addition to the patient's pulse rate obtained from any one of sites. Further, the DSP <b>150</b> can provide unique outputs unavailable from conventional pulse oximeters. These outputs <b>164</b> include venous oxygen saturation, Sp<sub>v</sub>O<sub>2</sub>, a comparison of arterial and venous oxygen saturation, Δ<sub>sat</sub>=Sp<sub>av</sub>O<sub>2</sub>=Sp<sub>a</sub>O<sub>2</sub>−Sp<sub>v</sub>O<sub>2</sub>, and pleth, which denotes plethysmograph shape parameters, for each site. In addition, the DSP <b>150</b> can provide cross-site outputs that are only available using stereo pulse oximetry. These unique cross-site outputs <b>168</b> include Δsat<sub>xy</sub>=Sp<sub>ax</sub>O<sub>2</sub>−Sp<sub>ay</sub>O<sub>2</sub>, which denotes the arterial oxygen saturation at site x minus the arterial oxygen saturation at site y. Also included in these outputs <b>168</b> is Δpleth<sub>xy</sub>, which denotes a comparison of plethysmograph shape parameters measured at site x and site y, as described in detail below. The stereo pulse oximeter also includes a display <b>180</b> capable of showing the practitioner the oxygen status and plethysmograph parameters described above. The display <b>180</b> has a multiple channel graphical and numerical display capability as described in more detail below.</p>
    <p num="p-0044">Pulse Oximetry Sensor</p>
    <p num="p-0045"> <figref idrefs="DRAWINGS">FIG. 2</figref> depicts one stereo pulse oximeter data channel having a sensor <b>110</b> and a sensor interface <b>114</b> providing a single data channel input <b>152</b> to the DSP <b>150</b>. The sensor <b>110</b> is used to measure the intensity of red and infrared light after transmission through a portion of the body where blood flows close to the surface, such as a fingertip <b>202</b>. The sensor <b>110</b> has two light emitters, each of which may be, for example, a light-emitting diode (LED). A red emitter <b>212</b>, which transmits light centered at a red wavelength and an infrared (IR) emitter <b>214</b>, which transmits light centered at an infrared wavelength are placed adjacent to, and illuminate, a tissue site. A detector <b>218</b>, which may be a photodiode, is used to detect the intensity of the emitted light after it passes through, and is partially absorbed by, the tissue site. The emitters <b>212</b>, <b>214</b> and detector <b>218</b> are secured to the tissue site, with the emitters <b>212</b>, <b>214</b> typically spaced on opposite sides of the tissue site from the detector <b>218</b>.</p>
    <p num="p-0046">To distinguish between tissue absorption at the two wavelengths, the red emitter <b>212</b> and infrared emitter <b>214</b> are modulated so that only one is emitting light at a given time. In one embodiment, the red emitter <b>212</b> is activated for a first quarter cycle and is off for the remaining three-quarters cycle; the infrared emitter <b>214</b> is activated for a third quarter cycle and is off for the remaining three-quarters cycle. That is, the emitters <b>212</b>, <b>214</b> are cycled on and off alternately, in sequence, with each only active for a quarter cycle and with a quarter cycle separating the active times. The detector <b>218</b> produces an electrical signal corresponding to the red and infrared light energy attenuated from transmission through the patient tissue site <b>202</b>. Because only a single detector <b>218</b> is used, it receives both the red and infrared signals to form a time-division-multiplexed (TDM) signal. This TDM signal is coupled to the input <b>112</b> of the sensor interface <b>114</b>. One of ordinary skill in the art will appreciate alternative activation sequences for the red emitter <b>212</b> and infrared emitter <b>214</b> within the scope of this invention, each of which provides a time multiplexed signal from the detector <b>218</b> allowing separation of red and infrared signals and determination and removal of ambient light levels in downstream signal processing.</p>
    <p num="p-0047">To compute Sp<sub>a</sub>O<sub>2</sub>, pulse oximetry relies on the differential light absorption of oxygenated hemoglobin, HbO<sub>2</sub>, and deoxygenated hemoglobin, Hb, to compute their respective concentrations in the arterial blood. This differential absorption is measured at the red and infrared wavelengths of the sensor <b>110</b>. The relationship between arterial oxygen saturation and hemoglobin concentration can be expressed as:</p>
    <p num="p-0048"> <maths id="MATH-US-00001" num="00001"> <math overflow="scroll"> <mtable> <mtr> <mtd> <mrow> <mrow> <msub> <mi>Sp</mi> <mi>a</mi> </msub> <mo>⁢</mo> <msub> <mi>O</mi> <mn>2</mn> </msub> </mrow> <mo>=</mo> <mrow> <mn>100</mn> <mo>⁢</mo> <mfrac> <msub> <mi>C</mi> <mrow> <mi>HbO</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mn>2</mn> </mrow> </msub> <mrow> <msub> <mi>C</mi> <mi>Hb</mi> </msub> <mo>+</mo> <msub> <mi>C</mi> <mrow> <mi>HbO</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mn>2</mn> </mrow> </msub> </mrow> </mfrac> </mrow> </mrow> </mtd> <mtd> <mrow> <mo>(</mo> <mn>1</mn> <mo>)</mo> </mrow> </mtd> </mtr> </mtable> </math> </maths> <br>
That is, arterial oxygen saturation is the percentage concentration of oxygenated hemoglobin compared to the total concentration of oxygenated hemoglobin and deoxygenated hemoglobin in the arterial blood. Sp<sub>a</sub>O<sub>2 </sub>is actually a measure of the partial oxygen saturation of the hemoglobin because other hemoglobin derivatives, such as COHb and MetHb, are not taken into consideration.
</p>
    <p num="p-0049"> <figref idrefs="DRAWINGS">FIG. 3</figref> shows a graph <b>300</b> of the optical absorption properties of HbO<sub>2 </sub>and Hb. The graph <b>300</b> has an x-axis <b>310</b> corresponding to wavelength and a y-axis <b>320</b> corresponding to hemoglobin absorption. An Hb curve <b>330</b> shows the light absorption properties of deoxygenated hemoglobin. An HbO<sub>2 </sub>curve <b>340</b> shows the light absorption properties of oxygenated hemoglobin. Pulse oximetry measurements are advantageously made at a red wavelength <b>350</b> corresponding to 660 nm and an infrared wavelength <b>360</b> corresponding to 905 nm. This graph <b>300</b> shows that, at these wavelengths <b>350</b>, <b>360</b>, deoxygenated hemoglobin absorbs more red light than oxygenated hemoglobin, and, conversely, oxygenated hemoglobin absorbs more infrared light than deoxygenated hemoglobin.</p>
    <p num="p-0050">In addition to the differential absorption of hemoglobin derivatives, pulse oximetry relies on the pulsatile nature of arterial blood to differentiate hemoglobin absorption from absorption of other constituents in the surrounding tissues. Light absorption between systole and diastole varies due to the blood volume change from the inflow and outflow of arterial blood at a peripheral tissue site. This tissue site might also comprise skin, muscle, bone, venous blood, fat, pigment, etc., each of which absorbs light. It is assumed that the background absorption due to these surrounding tissues is invariant and can be ignored. Thus, blood oxygen saturation measurements are based upon a ratio of the time-varying or AC portion of the detected red and infrared signals with respect to the time-invariant or DC portion. This AC/DC ratio normalizes the signals and accounts for variations in light pathlengths through the measured tissue. Further, a ratio of the normalized absorption at the red wavelength over the normalized absorption at the infrared wavelength is computed:</p>
    <p num="p-0051"> <maths id="MATH-US-00002" num="00002"> <math overflow="scroll"> <mtable> <mtr> <mtd> <mrow> <mfrac> <mi>RD</mi> <mi>IR</mi> </mfrac> <mo>=</mo> <mfrac> <mrow> <mo>(</mo> <mfrac> <msub> <mi>Red</mi> <mrow> <mi>A</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>C</mi> </mrow> </msub> <msub> <mi>Red</mi> <mrow> <mi>D</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>C</mi> </mrow> </msub> </mfrac> <mo>)</mo> </mrow> <mrow> <mo>(</mo> <mfrac> <msub> <mi>IR</mi> <mrow> <mi>A</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>C</mi> </mrow> </msub> <msub> <mi>IR</mi> <mrow> <mi>D</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>C</mi> </mrow> </msub> </mfrac> <mo>)</mo> </mrow> </mfrac> </mrow> </mtd> <mtd> <mrow> <mo>(</mo> <mn>2</mn> <mo>)</mo> </mrow> </mtd> </mtr> </mtable> </math> </maths> <br>
where Red<sub>AC </sub>and IR<sub>AC </sub>are the root-mean-square (RMS) of the corresponding time-varying signals. This “red-over-infrared, ratio-of-ratios” cancels the pulsatile signal. The desired Sp<sub>a</sub>O<sub>2 </sub>measurement is then computed from this ratio.
</p>
    <p num="p-0052"> <figref idrefs="DRAWINGS">FIG. 4</figref> shows a graph <b>400</b> depicting the relationship between RD/IR and Sp<sub>a</sub>O<sub>2</sub>. This relationship can be approximated from Beer-Lambert's Law, as outlined below. However, it is most accurately determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of oxygen saturation. The result can be depicted as a curve <b>410</b>, with measured values of RD/IR shown on a y-axis <b>420</b> and corresponding saturation values shown on an x-axis <b>430</b>. In a pulse oximeter device, this empirical relationship can be stored in a read-only memory (ROM) look-up table so that Sp<sub>a</sub>O<sub>2 </sub>can be directly read-out from input RD/IR measurements.</p>
    <p num="p-0053">According to the Beer-Lambert law of absorption, the intensity of light transmitted through an absorbing medium is given by:</p>
    <p num="p-0054"> <maths id="MATH-US-00003" num="00003"> <math overflow="scroll"> <mtable> <mtr> <mtd> <mrow> <mi>I</mi> <mo>=</mo> <mrow> <msub> <mi>I</mi> <mn>0</mn> </msub> <mo>⁢</mo> <mrow> <mi>exp</mi> <mo>⁡</mo> <mrow> <mo>(</mo> <mrow> <mo>-</mo> <mrow> <munderover> <mo>∑</mo> <mrow> <mi>i</mi> <mo>=</mo> <mn>1</mn> </mrow> <mi>N</mi> </munderover> <mo>⁢</mo> <mrow> <msub> <mi>ɛ</mi> <mrow> <mi>i</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>λ</mi> </mrow> </msub> <mo>⁢</mo> <msub> <mi>c</mi> <mi>i</mi> </msub> <mo>⁢</mo> <msub> <mi>x</mi> <mi>i</mi> </msub> </mrow> </mrow> </mrow> <mo>)</mo> </mrow> </mrow> </mrow> </mrow> </mtd> <mtd> <mrow> <mo>(</mo> <mn>3</mn> <mo>)</mo> </mrow> </mtd> </mtr> </mtable> </math> </maths> <br>
where I<sub>0 </sub>is the intensity of the incident light, ε<sub>i,λ. </sub>is the absorption coefficient of the i<sup> <u>th</u> </sup> constituent at a particular wavelength λ, c<sub>i </sub>is the concentration coefficient of the i<sup> <u>th</u> </sup> constituent and x<sub>i </sub>is the optical path length of the i<sup> <u>th</u> </sup> constituent. As stated above, assuming the absorption contribution by all constituents but the arterial blood is constant, taking the natural logarithm of both sides of equation (3) and removing time invariant terms yields:
<br>ln(<i>I</i>)=−[ε<sub>HbO2,λ</sub> <i>C</i> <sub>HbO2</sub>+ε<sub>Hb,λ</sub> <i>C</i> <sub>hb</sub> <i>]X</i>(<i>t</i>)  (4)<br>
Measurements taken at both red and infrared wavelengths yield:
<br> <i>RD</i>(<i>t</i>)=−[ε<sub>HbO2,RD</sub> <i>C</i> <sub>HbO2</sub>+ε<sub>Hb,RD</sub> <i>C</i> <sub>hb</sub> <i>]X</i> <sub>RD</sub>(<i>t</i>)  (5)<br> <i>IR</i>(<i>t</i>)=−[ε<sub>HbO2,IR</sub> <i>C</i> <sub>HbO2</sub>+ε<sub>Hb,IR</sub> <i>C</i> <sub>hb</sub> <i>]X</i> <sub>IR</sub>(<i>t</i>)  (6)<br>
Taking the ratio RD(t)/IR(t) and assuming X<sub>RD</sub>(t)≈X<sub>IR</sub>(t) yields:
<br> <i>RD/IR=[ε</i> <sub>HbO2,RD</sub> <i>C</i> <sub>HbO2</sub>+ε<sub>Hb,RD</sub> <i>C</i> <sub>Hb</sub>]/[ε<sub>HbO2,IR</sub> <i>C</i> <sub>HbO2</sub>+ε<sub>Hb,IR</sub> <i>C</i> <sub>hb</sub>]  (7)<br>
Assuming further that:
<br> <i>C</i> <sub>HbO2</sub> <i>+C</i> <sub>Hb</sub>=1  (8)<br>
then equation (1) can be solved in terms of RD/IR yielding a curve similar to the graph <b>400</b> of <figref idrefs="DRAWINGS">FIG. 4</figref>.
</p>
    <p num="p-0055">Sensor Interface</p>
    <p num="p-0056"> <figref idrefs="DRAWINGS">FIG. 2</figref> also depicts the sensor interface <b>114</b> for one data channel. An interface input <b>112</b> from the sensor <b>110</b> is coupled to an analog signal conditioner <b>220</b>. The analog signal conditioner <b>220</b> has an output <b>223</b> coupled to an analog-to-digital converter (ADC) <b>230</b>. The ADC output <b>118</b> is coupled to the DSP <b>150</b>. The analog signal conditioner also has a gain control input <b>225</b> from the DSP <b>150</b>. The functions of the analog signal conditioner <b>220</b> are explained in detail below. The ADC <b>230</b> functions to digitize the input signal <b>112</b> prior to further processing by the DSP <b>150</b>, as described below. The sensor interface <b>114</b> also has an emitter current control input <b>241</b> coupled to a digital-to-analog converter (DAC) <b>240</b>. The DSP provides control information to the DAC <b>240</b> via the control input <b>241</b> for a pair of emitter current drivers <b>250</b>. One driver output <b>252</b> couples to the red emitter <b>212</b> of the sensor <b>110</b>, and another driver output <b>254</b> couples to the IR emitter <b>214</b> of the sensor <b>110</b>.</p>
    <p num="p-0057"> <figref idrefs="DRAWINGS">FIG. 5</figref> illustrates one embodiment of the analog signal conditioner <b>220</b>. The analog signal conditioner <b>220</b> receives a composite intensity signal <b>112</b> from the sensor detector <b>218</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>) and then filters and conditions this signal prior to digitization. The embodiment shown has a preamplifier <b>510</b>, a high pass filter <b>520</b>, a programmable gain amplifier <b>530</b> and a low pass filter <b>540</b>. The low pass filter output <b>223</b> is coupled to the ADC <b>230</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>). The preamplifier <b>510</b> converts the current signal <b>112</b> from the detector <b>218</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>) to a corresponding amplified voltage signal. The gain in the preamplifier <b>510</b> is selected in order to prevent ambient light in the signal <b>112</b> from saturating the preamplifier <b>510</b> under normal operating conditions. The preamplifier output <b>512</b> is coupled to the high pass filter <b>520</b>, which removes the DC component of the detector signal <b>112</b>. The corner frequency of the high pass filter <b>520</b> is set well below the multiplexing frequency of the red and infrared emitters <b>212</b>, <b>214</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>). The high pass filter output <b>522</b> couples to the programmable gain amplifier <b>530</b>, which also accepts a programming input <b>225</b> from the DSP <b>150</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>). This gain is set at initialization or at sensor placement to compensate for variations from patient to patient. The programmable gain amplifier output <b>532</b> couples to a low-pass filter <b>540</b> to provide anti-aliasing prior to digitization.</p>
    <p num="p-0058">As described above, pulse oximetry measurements rely on the existence of a pulsatile signal. The natural heart beat provides a pulsatile signal that allows measurement of arterial oxygen saturation. In the systemic circulation, all arterial pulsations are damped before flow enters the capillaries, and none are transmitted into the veins. Thus, there is no arterial pulse component in the venous blood and absorption caused by venous blood is assumed canceled by the ratio-of-ratio operation described above. Venous blood, being at a relatively low pressure, will “slosh back and forth” during routine patient motions, such as shivering, waving and tapping. This venous blood sloshing creates a time-varying signal that is considered “noise” and can easily overwhelm conventional ratio-based pulse oximeters. Advanced pulse oximetry techniques allow measurement of Sp<sub>v</sub>O<sub>2 </sub>under these circumstances. For example, such advanced techniques are disclosed in U.S. Pat. No. 5,632,272, which is assigned to the assignee of the current application. This measurement is only available during motion or other physiological events causing a time-varying venous signal.</p>
    <p num="p-0059">The venous blood may also have a pulsatile component at the respiration rate, which can be naturally induced or ventilator induced. In adults, the natural respiration rate is 10-15 beats per minute (bpm). In neonates, this natural respiration rate is 30-60 bpm. The ventilator induced pulse rate depends on the ventilator frequency. If this respiration induced venous pulse is of sufficient magnitude, advanced pulse oximetry techniques, described below, allow measurement of Sp<sub>v</sub>O<sub>2</sub>.</p>
    <p num="p-0060">A controlled physiological event, however, can be created that allows for a continuous measurement of venous oxygen saturation, independent of motion or respiration. U.S. Pat. No. 5,638,816, which is assigned to the assignee of the current application discloses a technique for inducing an intentional active perturbation of the blood volume of a patient, and is referred to as an “active pulse.” Because peripheral venous oxygen saturation, Sp<sub>v</sub>O<sub>2</sub>, is a desirable parameter for stereo pulse oximetry applications, it is advantageous to provide for a continuous and controlled pulsatile venous signal.</p>
    <p num="p-0061"> <figref idrefs="DRAWINGS">FIG. 2</figref> depicts an active pulse mechanism used in conjunction with a pulse oximetry sensor. An active pulser <b>260</b> physically squeezes or otherwise perturbs a portion of patient tissue <b>270</b> in order to periodically induce a “pulse” in the blood at the tissue site <b>202</b>. A pulser drive <b>280</b> generates a periodic electrical signal to a transducer <b>262</b> attached to the patient. The transducer <b>262</b> creates a mechanical force against the patient tissue <b>270</b>. For example, the pulser <b>260</b> could be a solenoid type device with a plunger that presses against the fleshy tissue to which it is attached. The DSP <b>150</b> provides pulse drive control information to a digital to analog converter (DAC) <b>290</b> via the control input <b>291</b>. The DAC output <b>292</b> is coupled to the pulser drive <b>280</b>. This allows the processor to advantageously control the magnitude of the induced pulse, which moderates scattering as described below. The pulser <b>260</b> could be a pressure device as described above. Other pressure mechanisms, for example a pressure cuff, could be similarly utilized. Other methods, such as temperature fluctuations or other physiological changes, which physiologically alter a fleshy medium of the body on a periodic basis to modulate blood volume at a nearby tissue site could also be used. Regardless of the active pulse mechanism, this modulated blood volume is radiated by a pulse oximeter sensor and the resulting signal is processed by the signal processing apparatus described below to yield Sp<sub>v</sub>O<sub>2</sub>.</p>
    <p num="p-0062">Signal Processor</p>
    <p num="p-0063"> <figref idrefs="DRAWINGS">FIG. 6</figref> illustrates the processing functions of the digital signal processor (DSP) <b>150</b> (<figref idrefs="DRAWINGS">FIG. 1A</figref>). Each data channel input <b>152</b>, <b>154</b>, <b>158</b> (<figref idrefs="DRAWINGS">FIG. 1A</figref>) is operated on by one or more of the front-end processor <b>610</b>, saturation calculator <b>620</b>, plethysmograph feature extractor <b>630</b> and multiple parameter processor <b>640</b> functions of the DSP <b>150</b>. First, a digitized signal output from the ADC <b>230</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>) is input <b>602</b> to the front-end processor <b>610</b>, which demultiplexes, filters, normalizes and frequency transforms the signal, as described further below. A front-end output <b>612</b> provides a red signal spectrum and an IR signal spectrum for each data channel as inputs to the saturation calculator <b>620</b>. Another front-end output <b>614</b> provides a demultiplexed, normalized IR plethysmograph for each data channel as an input to the feature extractor <b>630</b>. The saturation calculator output <b>622</b> provides arterial and venous saturation data for each data channel as input to the multiple parameter processor <b>640</b>. One feature extractor output <b>632</b> provides data on various plethysmograph shape parameters for each data channel as input into the multiple parameter processor <b>640</b>. Another feature extractor output <b>634</b>, also coupled to multiple parameter processor <b>640</b>, provides an indication of plethysmograph quality and acts as a threshold for determining whether to ignore portions of the input signal <b>602</b>. The multiple parameter processor has a numerical output <b>642</b> that provides same-channel Δsat parameters and cross-channel parameters, such as Δsat<sub>xy </sub>or Δpleth<sub>xy </sub>to a display <b>180</b> (<figref idrefs="DRAWINGS">FIG. 1A</figref>). The numeric output <b>642</b> may also provide saturation and plethysmograph parameters directly from the saturation calculator <b>620</b> or the feature extractor <b>630</b> without further processing other than data buffering. The multiple parameter processor also has a graphical output <b>644</b> that provides plethysmograph waveforms for each data channel in addition to graphics, depending on a particular application, the indicate the trend of the numerical parameters described above.</p>
    <p num="p-0064">Front-End Processor</p>
    <p num="p-0065"> <figref idrefs="DRAWINGS">FIG. 7</figref> is a functional block diagram of the front-end processor <b>610</b> for the stereo pulse oximeter. The digitized sensor output <b>118</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>) is an input signal <b>602</b> to a demultiplexer <b>710</b>, which separates the input signal <b>602</b> into a red signal <b>712</b> and an infrared signal <b>714</b>. The separated red and infrared signals <b>712</b>, <b>714</b> are each input to a filter <b>720</b> to remove unwanted artifacts introduced by the demultiplexing operation. In one embodiment, the filter <b>720</b> is a finite-impulse-response, low-pass filter that also “decimates” or reduces the sample rate of the red and infrared signals <b>712</b>, <b>714</b>. The filtered signals <b>722</b> are then each normalized by a series combination of a log function <b>730</b> and bandpass filter <b>740</b>. The normalized signals, RD(t), IR(t) <b>742</b> are coupled to a Fourier transform <b>750</b>, which provides red frequency spectrum and infrared frequency spectrum outputs, RD(ω), IR(ω) <b>612</b>. A demultiplexed infrared signal output <b>614</b> is also provided.</p>
    <p num="p-0066">Saturation Calculator</p>
    <p num="p-0067"> <figref idrefs="DRAWINGS">FIG. 8</figref> shows a graph <b>800</b> illustrating idealized spectrums of RD(t) and IR(t) <b>752</b> (<figref idrefs="DRAWINGS">FIG. 7</figref>). The graph has an x-axis <b>810</b> that corresponds to the frequency of spectral components in these signals and a y-axis <b>820</b> that corresponds to the magnitude of the spectral components. The spectral components are the frequency content of RD(t) and IR(t), which are plethysmograph signals corresponding to the patient's pulsatile blood flow, as described below. Thus, the frequencies shown along the x-axis <b>810</b>, i.e. f<sub>0</sub>, f<sub>1</sub>, f<sub>2</sub>, are the fundamental and harmonics of the patient's pulse rate. The spectrum of RD(t), denoted RD(ω) <b>612</b> (<figref idrefs="DRAWINGS">FIG. 7</figref>), is shown as a series of peaks, comprising a first peak <b>832</b> at a fundamental frequency, f<sub>0</sub>, a second peak <b>842</b> at a first harmonic, f<sub>1 </sub>and a third peak <b>852</b> at a second harmonic, f<sub>2</sub>. Similarly, the spectrum of IR(t), denoted IR(ω) <b>612</b> (<figref idrefs="DRAWINGS">FIG. 7</figref>), is shown as another series of peaks, comprising a first peak <b>834</b> at a fundamental frequency, f<sub>0</sub>, a second peak <b>844</b> at a first harmonic, f<sub>1 </sub>and a third peak <b>854</b> at a second harmonic, f<sub>2</sub>. Also shown in <figref idrefs="DRAWINGS">FIG. 8</figref> is the ratio of the spectral peaks of RD(t) and IR(t), denoted RD(ω)/IR(ω). This ratio is shown as a first ratio line <b>838</b> at the fundamental frequency f<sub>0</sub>, a second ratio line <b>848</b> at the first harmonic f<sub>1</sub>, and a third ratio line <b>858</b> at the second harmonic f<sub>2</sub>.</p>
    <p num="p-0068">The magnitude of these ratio lines RD(ω)/IR(ω) corresponds to the ratio RD/IR defined by equation (2), and, hence, can be used to determine Sp<sub>a</sub>O<sub>2</sub>. This can be seen from Parseval's relation for a periodic signal, x(t), having a period T, where X<sub>k </sub>is the spectral component at the kth harmonic of x(t):</p>
    <p num="p-0069"> <maths id="MATH-US-00004" num="00004"> <math overflow="scroll"> <mtable> <mtr> <mtd> <mrow> <mrow> <mfrac> <mn>1</mn> <mi>T</mi> </mfrac> <mo>⁢</mo> <mrow> <msubsup> <mo>∫</mo> <mn>0</mn> <mi>T</mi> </msubsup> <mo>⁢</mo> <mrow> <msup> <mrow> <mo>(</mo> <mrow> <mo></mo> <mrow> <mi>x</mi> <mo>⁡</mo> <mrow> <mo>(</mo> <mi>t</mi> <mo>)</mo> </mrow> </mrow> <mo></mo> </mrow> <mo>)</mo> </mrow> <mn>2</mn> </msup> <mo>⁢</mo> <mstyle> <mspace width="0.2em" height="0.2ex"> </mspace> </mstyle> <mo>⁢</mo> <mrow> <mo>ⅆ</mo> <mi>t</mi> </mrow> </mrow> </mrow> </mrow> <mo>=</mo> <mrow> <munder> <mo>∑</mo> <mi>k</mi> </munder> <mo>⁢</mo> <msup> <mrow> <mo>(</mo> <mrow> <mo></mo> <msub> <mi>X</mi> <mi>k</mi> </msub> <mo></mo> </mrow> <mo>)</mo> </mrow> <mn>2</mn> </msup> </mrow> </mrow> </mtd> <mtd> <mrow> <mo>(</mo> <mn>9</mn> <mo>)</mo> </mrow> </mtd> </mtr> </mtable> </math> </maths> <br>
Equation (9) relates the energy in one period of the signal x(t) to the sum of the squared magnitudes of the spectral components. The term |X<sub>k</sub>|<sup>2 </sup>can be interpreted as that part of the energy per period contributed by the kth harmonic. In an ideal measurement, the red and infrared signals are the same to within a constant scale factor, which corresponds to the arterial oxygen saturation. Likewise, the red and infrared spectra are also the same to within a constant scale factor. Thus, in an ideal measurement, all of the ratio lines <b>838</b>, <b>848</b>, <b>858</b> have substantially the same amplitude. Any differences in the amplitude of the ratio lines is likely due to motion, scattering or other noise contaminations, as discussed further below. Accordingly, any of the RD(ω)/IR(ω) ratio lines is equivalent to the ratio, RD/IR, of equation (2) and can be used to derive Sp<sub>a</sub>O<sub>2</sub>.
</p>
    <p num="p-0070">One skilled in the art will recognize that the representations in <figref idrefs="DRAWINGS">FIG. 8</figref> are idealized. In particular, in actual measured data, especially if contaminated by noise, the frequencies of the peaks of RD(ω) do not correspond exactly to the frequencies of the peaks of IR(ω). For example, the fundamental frequency, f<sub>0</sub>, found for RD(ω) will often be different from the fundamental frequency, f<sub>0</sub>′, found for IR(ω) and similarly for the harmonics of f<sub>0</sub>.</p>
    <p num="p-0071"> <figref idrefs="DRAWINGS">FIG. 9</figref> shows a graph <b>900</b> illustrating idealized spectrums RD(ω) and IR(ω) and associated ratio lines measured with an active pulse sensor. The graph <b>900</b> has an x-axis <b>910</b> that corresponds to the frequency of spectral components in these signals and a y-axis <b>920</b> that corresponds to the magnitude of the spectral components. The spectrum, RD(ω), is shown as two series of peaks. One series of peaks <b>930</b> occurs at a fundamental frequency, f<sub>h0</sub>, and associated harmonics, f<sub>h1 </sub>and f<sub>h2</sub>, of the patient's pulse (heart) rate. Another series of peaks <b>940</b> occurs at a fundamental frequency, f<sub>p0</sub>, and associated harmonics, f<sub>p1 </sub>and f<sub>p2</sub>, of the active pulse rate. Similarly, the spectrum, IR(ω), is shown as two series of peaks. One series of peaks <b>950</b> occurs at a fundamental frequency, f<sub>h0</sub>, and associated harmonics, f<sub>h1 </sub>and f<sub>h2</sub>, of the patient's pulse rate. Another series of peaks <b>960</b> occurs at a fundamental frequency, f<sub>p0</sub>, and associated harmonics, f<sub>p1 </sub>and f<sub>p2</sub>, of the active pulse rate. Accordingly, there are two series of RD/IR ratio lines. One series of ratio lines <b>970</b> are at the patient's pulse rate and associated harmonics, and another series of ratio lines <b>980</b> are at the active pulser rate and associated harmonics.</p>
    <p num="p-0072">Because only the arterial blood is pulsatile at the patient's pulse rate, the ratio lines <b>970</b> are only a function of the arterial oxygen saturation. Accordingly, Sp<sub>a</sub>O<sub>2 </sub>can be derived from the magnitude of these ratio lines <b>970</b>, as described above. Further, a modulation level for the active pulse is selected which insignificantly perturbates the arterial blood while providing a measurable venous signal. This is possible because the arterial blood pressure is significantly larger than the venous pressure. The modulation level is regulated as described above with respect to <figref idrefs="DRAWINGS">FIG. 2</figref>, i.e. the DSP <b>150</b>, via a pulser drive control <b>291</b>, sets the magnitude of the pulser drive <b>280</b> to the pulse inducing mechanism <b>262</b>. Assuming that the active pulse modulation of the arterial blood is insignificant, only the venous blood is pulsatile at the active pulser rate. Hence, the ratio lines <b>980</b> are only a function of the venous oxygen saturation. Accordingly, Sp<sub>a</sub>O<sub>2 </sub>can be derived from the magnitude of the pulse rate related ratio lines <b>980</b> in the same manner as Sp<sub>a</sub>O<sub>2 </sub>is derived from the magnitude of the pulse rate related ratio lines.</p>
    <p num="p-0073">Scattering</p>
    <p num="p-0074">Propagation of optical radiation through tissue is affected by absorption and scattering processes. The operation of pulse oximeters was described qualitatively above using an analysis based on the Beer-Lambert law of absorption, equation (3). This approach, however, fails to account for the secondary effects of light scattering at pulse oximeter wavelengths. The primary light scatterer in blood is erythrocytes, i.e. red blood cells. A qualitative understanding of the effects of scattering on pulse oximetry is aided by a description of red blood cell properties within flowing blood.</p>
    <p num="p-0075">Human blood is a suspension of cells in an aqueous solution. The cellular contents are essentially all red blood cells, with white cells making up less the 1/600<sup>th </sup>of the total cellular volume and platelets less than 1/800<sup>th </sup>of the total cellular volume. Normally the hematocrit, which is the percentage of the total volume of blood occupied by cells, is about 50% in large vessels and 25% in small arterioles or venules.</p>
    <p num="p-0076">Red blood cells are extremely deformable, taking on various shapes in response to the hydrodynamic stresses created by flowing blood. For example, assuming a laminar blood flow within a vessel, a parabolic velocity profile exists that is greatest in the vessel center and smallest along the vessel walls. Nominally, red blood cells are shaped as biconcave disks with a diameter of 7.6 um and thickness of 2.8 um. Exposed to this velocity profile, the red blood cells become parachute-shaped and aligned in the direction of the blood flow. Thus, during systole, transmitted light is scattered by aligned, parachute-shaped cells. During diastole, the light is scattered by biconcave disks having a more or less random alignment.</p>
    <p num="p-0077">The time-varying shape and alignment of the red blood cells can have a significant effect on measured values of oxygen saturation if scattering is ignored. Analogous to the analysis using the Beer-Lambert absorption law, scattering can be qualitatively understood as a function of the scattering coefficients of various tissues. Specifically, the bulk scattering coefficient can be written as:
<br>μ<sub>s</sub> <i>=V</i> <sub>b</sub>μ<sub>b</sub> <i>+V</i> <sub>t</sub>μ<sub>t</sub>  (10)<br>
where V<sub>b </sub>is the blood volume, .μ<sub>b </sub>is the scattering coefficient of blood, V<sub>t </sub>is the surrounding tissue volume and .μ<sub>t </sub>is the scattering coefficient of the surrounding tissue. The volume, V<sub>t</sub>, and scattering coefficient, .μ<sub>t</sub>, of the surrounding tissue are time invariant. The blood volume, V<sub>b</sub>, however, is pulsatile. The ratio of ratios computation, RD/IR, results in normalization of the time invariant or DC tissue absorption and cancellation of the time varying or AC pulsatile blood volume absorption to yield a number related to oxygen saturation. This computational approach is valid because the absorption coefficients of blood, ε<sub>HbO2,λ</sub>, ε<sub>Hb,ε</sub> given in equation (4) were assumed to change only slowly over time. The scattering coefficient of blood .μ<sub>b</sub>, however, is time variant. As described above, this variation is due to the time-varying alignment and shape of the red blood cells. This time variation in the detected intensity of light transmitted through a tissue site is not normalized or canceled by the RD/IR calculation. Further, because the magnitude of the scattering coefficient variations is a function of blood flow, these variations become more pronounced with larger pulses in the blood supply. As a result, scattering produces frequency-dependent magnitude variations in the ratio lines RD(ω)/IR(ω).
</p>
    <p num="p-0078"> <figref idrefs="DRAWINGS">FIG. 9</figref> illustrates the effect of scattering on the spectra of the detected red and infrared intensity waveforms. When these waveforms are transformed into the frequency domain, the time varying component of scattering manifests itself as spreads <b>978</b>, <b>988</b> in the RD/IR ratio lines at each harmonic of the plethysmograph or active pulse rate. The magnitude of the ratio lines <b>970</b> at the fundamental and harmonics of the patient's pulse rate varies between a minimum <b>972</b> and a maximum <b>974</b>, resulting in a magnitude spread <b>978</b>. Similarly, the magnitude of the ratio lines <b>980</b> at the fundamental and harmonics of the active pulse rate varies between a minimum <b>982</b> and a maximum <b>984</b>, resulting in a magnitude spread <b>988</b>. Normally, absent motion artifact or noise contamination, the spread <b>978</b>, <b>988</b> in the ratio lines is quiet small, but the magnitude of these spreads <b>978</b>, <b>988</b>, increases with larger blood flows or pulse magnitudes. Scattering attributable to an active pulse can be regulated by adjusting the magnitude of the active pulse modulation based upon the amount of spread <b>978</b>, <b>988</b> of the ratio line magnitudes. Thus, the active pulse magnitude can be increased to obtain a larger detected AC signal, but limited to below the point at which scattering becomes significant.</p>
    <p num="p-0079"> <figref idrefs="DRAWINGS">FIG. 10</figref> depicts an embodiment of the signal processing for determining oxygen saturation from the ratio lines of RD(ω)/RD(ω). The red spectrum RD(ω) <b>612</b> and infrared spectrum IR(ω) <b>612</b>, computed as described above with respect to <figref idrefs="DRAWINGS">FIG. 7</figref>, are input to a peak detector <b>1010</b>. The peak detector <b>1010</b> separately calculates localized maximums for RD(ω) and IR(ω). The peak detector output <b>1012</b> is a series of frequencies corresponding to the patient pulse rate fundamental and harmonics. If an active pulse is used, the peak detector output <b>1012</b> is also a series of frequencies corresponding to the active pulse rate. Although the active pulse rate is known, the detected peaks may have been shifted due to noise, motion artifact or other signal contamination. The peak detector output <b>1012</b> is coupled to a series combination of peak matcher <b>1020</b> and ratio line calculator <b>1030</b>. The ratio lines RD/IR are calculated by matching the frequency peaks of RD(ω) with the nearest frequency peaks of IR(ω). The ratio lines associated with the pulse rate harmonics <b>1032</b> are then separated into a different set from the ratio lines associated with the active pulse harmonics <b>1034</b>, assuming an active pulse is utilized. An average ratio line for each set <b>1032</b>, <b>1034</b> is calculated by averaging <b>1060</b> all ratio lines in a set. The magnitude of the average ratio line r <b>1062</b> for the pulse rate set <b>1032</b> is then fed to a look-up table (LUT) <b>1090</b>, which provides an output <b>622</b> of the measured value of Sp<sub>a</sub>O<sub>2</sub>. Similarly, if an active pulse is used, the magnitude of the average ratio line μ <b>1064</b> for the active pulse rate set <b>1034</b> is then fed to a LUT <b>1090</b>, which provides an output <b>622</b> of the measured value of Sp<sub>v</sub>O<sub>2</sub>. A scattering detector <b>1080</b> computes the spread <b>988</b> (<figref idrefs="DRAWINGS">FIG. 9</figref>) in the set of ratio lines associated with the active pulse and provides this value <b>1082</b> to the DSP <b>150</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>) so that the DSP can set the pulser drive control <b>291</b> (<figref idrefs="DRAWINGS">FIG. 2</figref>) to regulate the magnitude of the active pulse.</p>
    <p num="p-0080">Alternatively, Sp<sub>v</sub>O<sub>2 </sub>may be measured from respiration-induced pulses in the venous blood, described above, without utilizing an active pulse sensor. Specifically, a series of ratio lines <b>980</b> (<figref idrefs="DRAWINGS">FIG. 9</figref>) would occur at a fundamental frequency, f<sub>r0</sub>, and associated harmonics, f<sub>r1 </sub>and f<sub>r2</sub>, of the respiration rate, which is either known from the ventilator frequency or derived from a separate measurement of the natural respiration. As shown in <figref idrefs="DRAWINGS">FIG. 10</figref>, the ratio lines associated with the respiration rate harmonics <b>1034</b> are then separated into a different set from the ratio lines associated with the pulse rate harmonics <b>1032</b>. An average ratio line for the respiration rate set <b>1034</b> is calculated by averaging <b>1060</b> all ratio lines in that set. The magnitude of the average ratio line μ <b>1064</b> for the respiration rate set <b>1034</b> is then fed to a look-up table (LUT) <b>1090</b>, which provides an output <b>622</b> of the measured value of Sp<sub>v</sub>O<sub>2</sub>.</p>
    <p num="p-0081">Plethysmograph Feature Extractor</p>
    <p num="p-0082"> <figref idrefs="DRAWINGS">FIG. 11</figref> illustrates the standard plethysmograph waveform <b>1100</b>, which can be derived from a pulse oximeter. The waveform <b>1100</b> is a visualization of blood volume change in the illuminated peripheral tissue caused by arterial blood flow, shown along the y-axis <b>1110</b>, over time, shown along the x-axis <b>1120</b>. The shape of the plethysmograph waveform <b>1100</b> is a function of heart stroke volume, pressure gradient, arterial elasticity and peripheral resistance. The ideal waveform <b>1100</b> displays a broad peripheral flow curve, with a short, steep inflow phase <b>1130</b> followed by a 3 to 4 times longer outflow phase <b>1140</b>. The inflow phase <b>1130</b> is the result of tissue distention by the rapid blood volume inflow during ventricular systole. During the outflow phase <b>1140</b>, blood flow continues into the vascular bed during diastole. The end diastolic baseline <b>1150</b> indicates the minimum basal tissue perfusion. During the outflow phase <b>1140</b> is a dicrotic notch <b>1160</b>, the nature of which is disputed. Classically, the dicrotic notch <b>1160</b> is attributed to closure of the aortic valve at the end of ventricular systole. However, it may also be the result of reflection from the periphery of an initial, fast propagating, pressure pulse that occurs upon the opening of the aortic valve and that precedes the arterial flow wave. A double dicrotic notch can sometimes be observed, although its explanation is obscure, possibly the result of reflections reaching the sensor at different times.</p>
    <p num="p-0083"> <figref idrefs="DRAWINGS">FIG. 12</figref> is a graph <b>1200</b> illustrating the absorption of light at a tissue site illuminated by a pulse oximetry sensor. The graph <b>1200</b> has a y-axis <b>1210</b> representing the total amount of light absorbed the tissue site, with time shown along an x-axis <b>1220</b>. The total absorption is represented by layers including the static absorption layers due to tissue <b>1230</b>, venous blood <b>1240</b> and a baseline of arterial blood <b>1250</b>. Also shown is a variable absorption layer due to the pulse-added volume of arterial blood <b>1260</b>. The profile <b>1270</b> of the pulse-added arterial blood <b>1260</b> is seen as the plethysmograph waveform <b>1100</b> depicted in <figref idrefs="DRAWINGS">FIG. 11</figref>.</p>
    <p num="p-0084"> <figref idrefs="DRAWINGS">FIG. 13</figref> illustrates the photoplethysmograph intensity signal <b>1300</b> detected by a pulse oximeter sensor. A pulse oximeter does not directly detect absorption, and hence does not directly measure the standard plethysmograph waveform <b>1100</b> (<figref idrefs="DRAWINGS">FIG. 11</figref>). However, the standard plethysmograph can be derived by observing that the detected intensity signal <b>1300</b> is merely an out of phase version of the absorption profile <b>1270</b>. That is, the peak detected intensity <b>1372</b> occurs at minimum absorption <b>1272</b> (<figref idrefs="DRAWINGS">FIG. 12</figref>), and minimum detected intensity <b>1374</b> occurs at maximum absorption <b>1274</b> (<figref idrefs="DRAWINGS">FIG. 12</figref>). Further, a rapid rise in absorption <b>1276</b> (<figref idrefs="DRAWINGS">FIG. 12</figref>) during the inflow phase of the plethysmograph is reflected in a rapid decline <b>1376</b> in intensity, and the gradual decline <b>1278</b> (<figref idrefs="DRAWINGS">FIG. 12</figref>) in absorption during the outflow phase of the plethysmograph is reflected in a gradual increase <b>1378</b> in detected intensity.</p>
    <p num="p-0085"> <figref idrefs="DRAWINGS">FIG. 14</figref> illustrates the digital signal processing for plethysmograph feature extraction <b>630</b> (<figref idrefs="DRAWINGS">FIG. 6</figref>). The input <b>614</b> is the IR signal output from the demultiplexer <b>710</b> (<figref idrefs="DRAWINGS">FIG. 7</figref>). This signal is shifted into a first-in, first-out (FIFO) buffer, which allows fixed-length portions of the input signal <b>614</b> to be processed for feature extraction. The buffered output signal <b>1412</b> is coupled to a shape detector <b>1420</b>, slope calculator <b>1430</b>, feature width calculator <b>1440</b> and a notch locator <b>1450</b>, which perform the core feature extraction functions. The shape detector <b>1420</b> determines if a particular buffered signal portion <b>1412</b> contains specific gross features, such as a peak, a valley, an upward slope, a downward slope, a dicrotic notch or a multiple dicrotic notch. A detected shape output <b>1422</b> containing one or more flags indicating the gross feature content of the current signal portion <b>1412</b> is coupled to the other feature extraction functions <b>1430</b>, <b>1440</b>, <b>1450</b> and to the waveform quality determination functions <b>1460</b>, <b>1470</b>, <b>1480</b>. A slope calculator <b>1430</b> determines the amount of positive or negative slope in the signal portion <b>1412</b> if the shape detector output <b>1422</b> indicates a slope is present. The output slope value <b>1432</b> is coupled to the waveform quality functions <b>1460</b>, <b>1470</b>, <b>1480</b> in addition to the feature extraction output <b>632</b>. A feature calculator <b>1440</b> quantifies a feature in one or more signal portions <b>1412</b> specified by the shape detector <b>1420</b>, such as the magnitude, the area under, or the width of a peak or notch. The feature calculator output <b>1442</b> is a code indicating the feature and its value, which is coupled to the feature extraction output <b>632</b>. A feature locator <b>1450</b> quantifies the time of occurrence of one or more features of a signal portion <b>1412</b> as specified by the shape detector <b>1420</b>. The feature locator output <b>1452</b>, which is coupled to the feature extraction output <b>632</b>, is a code indicating a feature and an associated code indicating time of occurrence in reference to a particular epoch. The feature locator output <b>1452</b> allows a determination of the relative location of plethysmograph features in addition to a phase comparison of plethysmographs derived from two or more tissue sites. Another feature extraction output <b>634</b>, which is coupled to the multiple parameter processor <b>640</b> (<figref idrefs="DRAWINGS">FIG. 6</figref>), provides an indication of waveform quality. Input signals portions <b>1412</b> not having either a sharp downward edge <b>1460</b>, a symmetrical peak <b>1470</b> or a gradual decline <b>1480</b> are not processed further.</p>
    <p num="p-0086">Multiple Parameter Processor</p>
    <p num="p-0087"> <figref idrefs="DRAWINGS">FIG. 15</figref> illustrates the multiple parameter processing portion <b>640</b> (<figref idrefs="DRAWINGS">FIG. 6</figref>) of the signal processing. A differencing function <b>1510</b> has as inputs a first saturation value, Sp<sub>1</sub>O<sub>2</sub>, and a second saturation value, Sp<sub>2</sub>O<sub>2</sub>, <b>622</b>. The saturation input values <b>622</b> can be arterial and venous saturation values from a single data channel, arterial saturation values from two different data channels or venous saturation values from two different data channels. The differences of the saturation value inputs <b>622</b> are provided as an output <b>1514</b>, which is coupled to a saturation data memory <b>1520</b>. The saturation values <b>622</b> are also directly coupled to the saturation data memory <b>1520</b>. The memory <b>1520</b> stores a record of saturation values, SpO<sub>2</sub>, for each channel, delta saturation values, Δsat, for each channel and cross-channel delta saturation values, Δsat<sub>xy</sub>, as required for a particular application. A flow calculator <b>1530</b> utilizes a plethysmograph input <b>614</b> or a bio-impedance probe input <b>1534</b> to provide a flow value <b>1538</b>, which is also coupled to the saturation data memory <b>1520</b>. For example, the flow value <b>1538</b> may be a perfusion index, PI, defined as follows:</p>
    <p num="p-0088"> <maths id="MATH-US-00005" num="00005"> <math overflow="scroll"> <mtable> <mtr> <mtd> <mrow> <mi>PI</mi> <mo>=</mo> <mfrac> <mrow> <msub> <mi>IR</mi> <mi>max</mi> </msub> <mo>-</mo> <msub> <mi>IR</mi> <mi>min</mi> </msub> </mrow> <msub> <mi>IR</mi> <mrow> <mi>D</mi> <mo>⁢</mo> <mstyle> <mspace width="0.3em" height="0.3ex"> </mspace> </mstyle> <mo>⁢</mo> <mi>C</mi> </mrow> </msub> </mfrac> </mrow> </mtd> <mtd> <mrow> <mo>(</mo> <mn>11</mn> <mo>)</mo> </mrow> </mtd> </mtr> </mtable> </math> </maths> <br>
where IR<sub>max </sub>is the maximum value, IR<sub>min </sub>is the minimum value, and IR<sub>DC </sub>is the average value of the IR plethysmograph signal <b>614</b> (<figref idrefs="DRAWINGS">FIG. 7</figref>).
</p>
    <p num="p-0089">The saturation data memory <b>1520</b> provides a buffered output <b>1522</b> that is coupled to a numerical display driver <b>1540</b>. The numerical display driver <b>1540</b> provides an output <b>642</b> to a standard display, such as LED or LCD numerical display modules or a CRT monitor. The memory output <b>1522</b> is also coupled to a saturation data analyzer <b>1530</b>, one function of which calculates a long-term trend of the values in memory <b>1520</b>. For example, the saturation data analyzer may average a saturation value over time, or provide samples of the saturation values taken at regular time intervals. The output <b>1532</b> can either be numerical, which is coupled to the numerical display driver <b>1540</b>, or graphical, which is coupled to the graphical display driver <b>1570</b>. The graphical display driver <b>1570</b> provides an output <b>644</b> to a standard graphical display device, such as LED or LCD graphical display modules or a CRT monitor.</p>
    <p num="p-0090">A pleth data memory <b>1550</b> has as inputs the IR plethysmograph signals <b>614</b> (<figref idrefs="DRAWINGS">FIG. 7</figref>) from each data channel and the associated extracted features <b>632</b> (<figref idrefs="DRAWINGS">FIG. 14</figref>). The memory <b>1550</b> also has an input indicating waveform quality <b>634</b> (<figref idrefs="DRAWINGS">FIG. 14</figref>). The pleth memory <b>1550</b> provides a buffered output <b>1558</b> that is coupled to the graphical display driver <b>1570</b>, allowing display of the plethysmograph waveforms for each data channel. The memory output <b>1558</b> is also coupled to a pleth data analyzer <b>1560</b>, one function of which calculates a long-term trend of the plethysmograph and shape parameters in pleth memory <b>1520</b>. For example, the pleth data analyzer <b>1560</b> may provide an average of particular shape parameters over time. As another example, the pleth data analyzer <b>1560</b> may provide a graphic showing an accumulation of many overlaid plethysmographs. The output <b>1562</b> can either be numerical, which is coupled to the numerical display driver <b>1540</b>, or graphical, which is coupled to the graphical display driver <b>1570</b>.</p>
    <p num="p-0091">Another function of the saturation data analyzer <b>1530</b> and the pleth data analyzer <b>1560</b> is to compare oxygen status and plethysmograph parameters derived from multiple sites in order to isolate noise artifacts and to derive a more accurate estimate of these parameters. For example, it is unlikely that motion artifact will affect each peripheral site in the same manner. If the quality input <b>634</b> indicates a noisy plethysmograph for one channel during a particular time period, the pleth data analyzer <b>1560</b> can exchange this information <b>1565</b> with the saturation data analyzer <b>1530</b>. The saturation data analyzer <b>1530</b> can then ignore the saturation data for that channel for that time period in lieu of saturation data from another channel. In a similar fashion, noisy data from multiple channels can be averaged, correlated or otherwise processed to provide an estimate of Sp<sub>a</sub>O<sub>2</sub>, Sp<sub>v</sub>O<sub>2 </sub>or pulse rate, or to provide a plethysmograph that is more accurate than can be derived from a single data channel.</p>
    <p num="p-0092"> <figref idrefs="DRAWINGS">FIG. 16A</figref> illustrates detail of a single-site display screen <b>180</b> for the stereo pulse oximeter. The display has a numerical display portion <b>1610</b> controlled by the numerical display driver <b>1540</b> (<figref idrefs="DRAWINGS">FIG. 15</figref>) and a graphical display portion <b>1660</b> controlled by the graphical display driver <b>1570</b> (<figref idrefs="DRAWINGS">FIG. 15</figref>). The numerical display portion <b>1610</b> displays a value for Sp<sub>a</sub>O<sub>2 </sub> <b>1620</b>, Sp<sub>v</sub>O<sub>2 </sub> <b>1630</b> and pulse rate <b>1640</b> for a particular tissue site. The graphical display portion <b>1660</b> displays a plethysmograph <b>1662</b> for the corresponding tissue site, which can be displayed as a single waveform or an accumulated multiple of overlayed waveforms that may reveal a waveform trend. A push button or menu selection allows the user to switch to a display of data from any single one of the multiple tissue sites to which a sensor is attached.</p>
    <p num="p-0093"> <figref idrefs="DRAWINGS">FIG. 16B</figref> illustrates detail of a multi-site display screen <b>180</b> for the stereo pulse oximeter. The numerical display portion <b>1610</b> displays a value for Sp<sub>a</sub>O<sub>2 </sub> <b>1622</b> and Sp<sub>v</sub>O<sub>2 </sub> <b>1632</b> for a first tissue site. Also displayed is a value for Sp<sub>a</sub>O<sub>2 </sub> <b>1624</b> and Sp<sub>v</sub>O<sub>2 </sub> <b>1634</b> for a second tissue site. In addition, a value for pulse rate <b>1642</b> derived from either the first or second tissue site, or both, is displayed. The graphical display portion <b>1660</b> displays a first plethysmograph <b>1664</b> and a second plethysmograph <b>1666</b> corresponding to the first and second tissue sites, respectively. A push button, menu selection allows the user to manually switch between the single site display (<figref idrefs="DRAWINGS">FIG. 16A</figref>) and the multi-site display (<figref idrefs="DRAWINGS">FIG. 16B</figref>). Also, a triggering event, such as an alarm based on multiple-site oxygen status parameters, causes the display to automatically switch from the single-site display to the multi-site display, enabling the user better view the conditions that caused the triggering event.</p>
    <p num="p-0094">One of ordinary skill will appreciate many display screens variations from those shown in <figref idrefs="DRAWINGS">FIGS. 16A and 16B</figref> that are within the scope of this invention. For example, the stereo pulse oximeter could be configured to provide several push button or menu selectable display screens. One display screen might display more than two channels of oxygen status data. Another display screen could display cross-channel parameters such as Δsat<sub>xy </sub>or a comparison of plethysmograph shape parameters from two channels. One of ordinary skill will also appreciate many variations and modifications of layout and design for the graphical and numerical displays within the scope of this invention.</p>
    <p num="p-0095">Stereo Pulse Oximetry Applications</p>
    <p num="p-0096">Oxygen Titration</p>
    <p num="p-0097">Oxygen is one of the most commonly used drugs in an intensive care unit and is an integral part of all respiratory support. The goal of oxygen therapy is to achieve adequate delivery of oxygen to the tissues without creating oxygen toxicity. Too little oxygen results in organ damage and, in particular, brain damage. Too much oxygen can result in, for example, pulmonary edema and, in neonates, retinopathy of prematurity (ROP). Infants receiving oxygen therapy, in particular, must have inspired oxygen concentration and blood oxygen levels monitored closely.</p>
    <p num="p-0098">Oxygen titration in neonates is currently accomplished with either transcutaneous monitoring or monitoring with a conventional pulse oximeter. As mentioned above, transcutaneous monitoring involves the placement of a heated Clark electrode against the skin surface. The electrode is secured to the skin surface with an airtight seal to eliminate contamination by room air gases. The skin surface beneath the electrode is then heated, which opens pre-capillary sphincters allowing localized arteriolar blood flow beneath the sensor. The so-called T<sub>c</sub>O<sub>2 </sub>value that is measured correlates well with P<sub>a</sub>O<sub>2</sub>. However, there are several drawbacks to this approach. Because the skin surface must be heated, a fifteen minute elapsed time after application is necessary before stable readings are acquired. Further, the required temperature is 43-45° C. (110° F.), with an associated risk of burns. In addition, titration is often accomplished by simply maintaining T<sub>c</sub>O<sub>2 </sub>within acceptable limits for this parameter, e.g. an equivalent P<sub>a</sub>O<sub>2 </sub>of 50-80 mm Hg for neonates. However, P<sub>a</sub>O<sub>2 </sub>alone does not provide an indication of balance between inspired oxygen and the rate of tissue oxygen consumption. If the patient is particularly anemic or hypovolemic, has an abnormal hemoglobin, or a small cardiac output, then oxygen delivery may be inadequate even in the presence of a normal P<sub>a</sub>O<sub>2</sub>. Titration with a conventional pulse oximeter is similarly accomplished by maintaining Sp<sub>a</sub>O<sub>2 </sub>within acceptable limits, which also fails to consider tissue oxygen consumption.</p>
    <p num="p-0099">Oxygen titration can be more adequately monitored with a continuous indication of oxygen consumption, which is equal to oxygen delivery according to Fick's algorithm, as noted above. Further, continuous monitoring of oxygen consumption at a peripheral tissue site, although not necessarily indicative of overall oxygen consumption, may be indicative of an oxygen supply dependency. A measure of peripheral oxygen consumption can be expressed in terms of Δsat=Sp<sub>a</sub>O<sub>2</sub>−Sp<sub>v</sub>O<sub>2 </sub>and perfusion, which, as noted above, are parameters advantageously provided by the stereo pulse oximeter according to the present invention. Oxygen consumption at a peripheral site is obtained by multiplying the difference between peripheral arterial and venous oxygen content by perfusion at the site.
<br> <i>Vp</i>O<sub>2</sub>=[O<sub>2 </sub>content (arterial)−O<sub>2 </sub>content (venous)]Φ  (12)<br>
where oxygen content is measured in milliliters (ml) of O<sub>2 </sub>per deciliters (dl) of blood and Φ denotes perfusion in deciliters per minute. Oxygen content, however, can be expressed in terms of the amount of oxygen bound to the hemoglobin plus the amount of oxygen dissolved in the plasma. The amount of bound oxygen is equal to the hemoglobin concentration, C<sub>hb</sub>, in grams per deciliter of blood, times the hemoglobin carrying capacity, which is 1.34 milliliters of O<sub>2 </sub>per gram of hemoglobin times the hemoglobin oxygen saturation, SO<sub>2</sub>. The amount of dissolved oxygen is simply the partial pressure of oxygen, PO<sub>2</sub>, times the O<sub>2 </sub>solubility coefficient in blood, which is 0.003 milliliters of O<sub>2 </sub>per deciliter. The sum of these two terms yields:
<br>O<sub>2 </sub>content=1.34<i>C</i> <sub>Hb</sub> <i>S</i>O<sub>2</sub>+0.003<i>P</i>O<sub>2</sub>  (13)<br>
Substituting equation (13) into equation (12) yields the following equation for tissue oxygen consumption:
<br> <i>Vp</i>O<sub>2</sub>=[1.34<i>C</i> <sub>Hb</sub>(<i>Sp</i> <sub>a</sub>O<sub>2</sub> <i>−Sp</i> <sub>v</sub>O<sub>2</sub>)+0.003(<i>P</i> <sub>a</sub>O<sub>2</sub> <i>−P</i> <sub>v</sub>O<sub>2</sub>)]Φ  (14)<br>
Except when the fractional inspired oxygen, FiO<sub>2</sub>, is high, blood plasma plays a minimal role in oxygen delivery. Thus, peripheral oxygen consumption is approximately:
<br>VpO<sub>2</sub>=[1.34C<sub>Hb</sub>Δsat]Φ  (15)</p>
    <p num="p-0100">In order to illustrate a schema of oxygen titration, it is convenient to characterize the relationship between oxygen supplied at the airway to oxygen consumed at a peripheral tissue site. Specifically, characterization of the relationship between Δsat, Φ and FiO<sub>2 </sub>is useful. Assuming constant oxygen consumption at the tissue site, equation (15) is:
<br>Δsat Φ=constant  (16)<br>
Equation (16) has a simple analog in electronic circuits, i.e. a variable resistor across a current or voltage source adjusted to maintain constant power. In this analog circuit, the current through the resistor, I, is equivalent to perfusion, the voltage across the resistor, V, is equivalent to Δsat and the constant of equation (16) is equivalent to the constant power, P, consumed by the resistor. The equation representing this electrical analog is:
<br> <i>V×I=P</i>  (17)</p>
    <p num="p-0101"> <figref idrefs="DRAWINGS">FIG. 17A</figref> shows a graph <b>1701</b> that depicts a family of curves each corresponding to different values of P in equation (17). The graph <b>1701</b> has an x-axis <b>1710</b> indicating current, I, and a y-axis <b>1720</b> indicating voltage, V. A first curve <b>1730</b> shows V versus I for a constant power, P, of 0.5 watts; a second curve <b>1740</b> shows V versus I for a constant P of 1 watt; and a third curve <b>1750</b> shows V versus I for a constant P of 2 watts. Using the analogy between equations (16) and equation (17), whenever Φ (current) is small, the Δsat (voltage) is large and vice-a-versa. Also, a change in consumption (power) causes a shift in the curve along with a change in its curvature. That is, if the body suddenly changes its metabolic rate at the peripheral tissue site, the curve will accordingly shift up or shift down and will change its shape. Equation (16) and the analogous constant consumption curves of <figref idrefs="DRAWINGS">FIG. 17A</figref> assume a supply independent condition, i.e. that peripheral oxygen consumption is satisfied by peripheral oxygen delivery. If the peripheral tissue site is starved for oxygen, then the locus of points for Δsat versus Φ is quite different from a hyperbola The amount of tissue oxygen extraction is at a maximum and is independent of Φ. Accordingly Δsat is at a maximum and independent of Φ. The above analysis provides insight into the relationship between Δsat and Φ. The relationship between Δsat and FiO<sub>2 </sub>can also be characterized.</p>
    <p num="p-0102"> <figref idrefs="DRAWINGS">FIG. 17B</figref> shows a graph <b>1702</b> of saturation along a y-axis <b>1760</b> and fractional inspired oxygen along an x-axis <b>1770</b>. A curve of Sp<sub>a</sub>O<sub>2 </sub> <b>1780</b> and a curve of Sp<sub>a</sub>O<sub>2 </sub> <b>1790</b> are depicted versus FiO<sub>2</sub>. The difference between these curves <b>1780</b>, <b>1790</b> yields Δsat <b>1785</b> versus FiO<sub>2</sub>. When FiO<sub>2 </sub>is zero <b>1772</b>, oxygen saturation and, hence, both Sp<sub>a</sub>O<sub>2 </sub> <b>1780</b> and Sp<sub>v</sub>O<sub>2 </sub> <b>1790</b> are zero. As FiO<sub>2 </sub>is increased, Sp<sub>a</sub>O<sub>2 </sub> <b>1780</b> also increases until virtually reaching 100 percent saturation <b>1762</b>. As FiO<sub>2 </sub>increases further, Sp<sub>a</sub>O<sub>2 </sub> <b>1780</b> stays at virtually 100 percent saturation <b>1762</b>. As FiO<sub>2 </sub>is increased from zero <b>1772</b>, Sp<sub>v</sub>O<sub>2 </sub> <b>1790</b> also increases. In this low FiO<sub>2 </sub>region <b>1774</b>, the peripheral tissue site is supply dependent and Δsat <b>1785</b> also increases. At a certain point, the tissue site oxygen demand is met by supply. In this supply independent region <b>1776</b>, oxygen consumption is constant and equation (16) is valid. Also, Δsat <b>1785</b> is at a constant maximum, which is a function of the metabolism at the tissue site. As FiO<sub>2 </sub>increases further, eventually the partial pressure of oxygen becomes significant and the second term of equation (14) must be considered. In this high FiO<sub>2 </sub>region <b>1778</b>, Δsat <b>1785</b> decreases because some of the tissue oxygen consumption is supplied by oxygen dissolved in the plasma.</p>
    <p num="p-0103"> <figref idrefs="DRAWINGS">FIG. 17C</figref> shows a graph <b>1704</b> of saturation difference along a y-axis <b>1764</b> and fractional inspired oxygen along an x-axis <b>1770</b>. A curve of Δsat <b>1786</b> is depicted versus FiO<sub>2</sub>, corresponding to the region Δsat <b>1785</b> depicted in <figref idrefs="DRAWINGS">FIG. 17B</figref>. The curve <b>1786</b> has a first deflection point <b>1766</b> occurring at the transition between the low FiO<sub>2 </sub>region <b>1774</b> (<figref idrefs="DRAWINGS">FIG. 17B</figref>) and the supply independent region <b>1776</b> (<figref idrefs="DRAWINGS">FIG. 17B</figref>). The curve <b>1786</b> also has a second deflection point <b>1768</b> occurring at the transition between the supply independent region <b>1776</b> (<figref idrefs="DRAWINGS">FIG. 17B</figref>) and the high FiO<sub>2 </sub>region <b>1778</b> (<figref idrefs="DRAWINGS">FIG. 17B</figref>). The curve <b>1786</b> illustrates how the trend for Δsat, as measured by the stereo pulse oximeter, can be used to accurately titrate oxygen. The goal of oxygen titration is to supply sufficient oxygen to supply tissue demand and avoid unnecessarily high amounts of FiO<sub>2</sub>. Thus, the Δsat parameter should be monitored so that FiO<sub>2 </sub>is adjusted between the two deflection points <b>1766</b>, <b>1768</b>. For neonates, FiO<sub>2 </sub>should be adjusted just beyond the first deflection point <b>1766</b>. For adults, FiO<sub>2 </sub>should be adjusted just before the second deflection point <b>1768</b>.</p>
    <p num="p-0104"> <figref idrefs="DRAWINGS">FIG. 18</figref> illustrates a graph having a three-dimensional surface <b>1800</b> generally depicting the relationship between Δsat, Φ and FiO<sub>2 </sub>from the combined graphs of <figref idrefs="DRAWINGS">FIGS. 17A and 17C</figref>. The graph has an x-axis <b>1810</b> showing FiO<sub>2</sub>, a y-axis <b>1820</b> showing Φ and a z-axis <b>1830</b> showing Δsat. The surface <b>1800</b> has a supply dependent region <b>1840</b>, a perfusion-limited region <b>1850</b>, a constant consumption region <b>1860</b> and a plasma dependent region <b>1870</b>. The surface describes the oxygen status of a peripheral tissue site. The supply dependent region <b>1840</b> corresponds to the low FiO<sub>2 </sub>region <b>1774</b> (<figref idrefs="DRAWINGS">FIG. 17B</figref>) described above. That is, inspired oxygen into the lungs is so low that, at the tissue site, oxygen extraction by the tissues is limited by oxygen delivery, and Δsat falls rapidly as FiO<sub>2 </sub>is reduced. The perfusion-limited region <b>1850</b> along the x-axis <b>1810</b> represents a low perfusion state where equation (16) is not valid. That is, perfusion at the tissue site is so low that oxygen extraction by the tissues is at a maximum, and, hence, Δsat is at a maximum and is independent of FiO<sub>2</sub>. A cross-section of the surface taken parallel to the y-axis <b>1820</b> yields a hyperbole-shaped constant consumption region <b>1860</b>, consistent with the constant metabolic rate curves illustrated above with respect to <figref idrefs="DRAWINGS">FIG. 17A</figref>. The plasma dependent region <b>1870</b> corresponds to the high FiO<sub>2 </sub>region <b>1778</b> (<figref idrefs="DRAWINGS">FIG. 17B</figref>) described above. That is, inspired oxygen into the lungs is so high that the tissue site is partially dependent on oxygen dissolved in the plasma The surface <b>1800</b> illustrates that perfusion should be monitored simultaneously with Δsat to avoid the perfusion-limited region <b>1850</b>, where Δsat is an unresponsive indicator of FiO<sub>2</sub>, and to avoid misinterpreting hyperbolic changes in Δsat that result from changes in perfusion.</p>
    <p num="p-0105">Persistent Pulmonary Hypertension in Neonates</p>
    <p num="p-0106"> <figref idrefs="DRAWINGS">FIG. 19</figref> illustrates the heart/lung circulation of a hypertensive neonate. Persistent Pulmonary Hypertension in Neonates (PPHN) is a neonatal condition with persistent elevation of pulmonary vascular resistance and pulmonary artery pressure. Shown is a neonatal heart <b>1902</b> and a portion of a neonatal lung <b>1904</b>. The pulmonary artery <b>1910</b> that normally feeds oxygen depleted “blue” blood from the right ventricle <b>1920</b> to the lung <b>1904</b> is constricted. The back pressure from the constricted artery <b>1910</b> results in a right-to-left shunting of this oxygen depleted blood through the ductus arteriosus <b>1930</b>, causing it to mix with oxygen rich “red” blood flowing through the descending aorta <b>1940</b>. PPHN treatment options include vasodilators, such as nitric oxide (NO). Inhaled exogenous NO causes a dose-dependent decrease in pulmonary artery pressure and pulmonary vascular resistance, as well as a parallel increase in pulmonary blood flow, without affecting systemic arterial pressure. However, the response to NO therapy is a function of the cause of the PPHN as well as the time elapsed before initiation of therapy. Potential toxic effects of NO dictate the proper titration of NO gas. Too little NO may not effectively relieve pulmonary hypertension, and too much NO may cause cellular injury or toxicity. NO therapy is currently monitored using intermittent ultrasound imaging and/or in vitro blood gas measurements. The drawbacks to these techniques are noncontinuous monitoring and disturbances to the neonate that can exacerbate or not reflect the hypertension in the non-disturbed state.</p>
    <p num="p-0107">The stereo pulse oximeter according to the present invention allows noninvasive, continuous monitoring of a neonate for detection and managed treatment of PPHN that does not disturb the patient. A right hand sensor <b>130</b> (<figref idrefs="DRAWINGS">FIG. 1</figref>) provides arterial oxygen saturation and a plethysmograph for blood circulating from the left ventricle <b>1950</b> through the innominate artery <b>1960</b>, which supplies the right subclavian artery. Because the innominate artery <b>1960</b> is upstream from the shunt at the ductus arteriosus <b>1930</b>, the oxygen saturation value and plethysmograph waveform obtained from the right hand are relatively unaffected by the shunt and serve as a baseline or reference for comparison with readings from other tissue sites. Alternatively, a reference sensor can be placed on a facial site, such as an ear, the nose or the lips. These sites provide arterial oxygen saturation and a plethysmograph for blood circulating from the left ventricle <b>1950</b> to the innominate artery <b>1960</b>, which supplies the right common carotid artery (not shown), or to the left common carotid artery <b>1965</b>.</p>
    <p num="p-0108">A foot sensor <b>120</b> (<figref idrefs="DRAWINGS">FIG. 1</figref>) provides oxygen status for blood supplied from the descending aorta <b>1940</b>. The shunt <b>1930</b> affects both the oxygen saturation and the blood flow in the descending aorta <b>1940</b>. As stated above, the shunt <b>1930</b> causes oxygen-depleted blood to be mixed with oxygen-rich blood in the descending aorta <b>1940</b>. Because the descending aorta <b>1940</b> supplies blood to the legs, the oxygen saturation readings at the foot will be lowered accordingly. The PPHN condition, therefore, is manifested as a higher arterial oxygen saturation at the right hand reference site and a lower saturation at the foot site.</p>
    <p num="p-0109">The shunt also allows a transitory left to right flow during systole, which distends the main pulmonary artery <b>1980</b> as the result of the blood flow pressure at one end from the right ventricle and at the other end from the aortic arch <b>1990</b>. A left-to-right flow through the shunt <b>1930</b> into the distended artery <b>1980</b> alters the flow in the descending aorta <b>1940</b> and, as a result, the plethysmograph features measured at the foot. The PPHN condition, therefore, also is manifested as a plethysmograph with a narrow peak and possibly a well-defined dicrotic notch at the left hand baseline site and a broadened peak and possibly no notch at the foot site.</p>
    <p num="p-0110">An optional left hand sensor <b>110</b> (<figref idrefs="DRAWINGS">FIG. 1</figref>) provides oxygen status for blood circulating from the left ventricle through the left subclavian artery <b>1970</b> that supplies the left arm. Because the left subclavian artery <b>1970</b> is nearer the shunt <b>1930</b> than the further upstream innominate artery <b>1960</b>, it may experience some mixing of deoxygenated blood and an alteration in flow due to the shunt <b>1930</b>. The PPHN condition, therefore, may also be manifested as a reduced saturation and an altered plethysmograph waveform at the left hand site as compared with the right hand baseline site, although to a lesser degree than with a foot site. Thus, the PPHN condition can be detected and its treatment monitored from Δsat and plethysmograph morphology comparisons between a right hand baseline sensor site and one or more other sites, such as the left hand or foot.</p>
    <p num="p-0111">Patent Ductus Arteriosus</p>
    <p num="p-0112"> <figref idrefs="DRAWINGS">FIG. 20</figref> illustrates the fetal heart/lung circulation. Shown is a fetal heart <b>2002</b> and a portion of a fetal lung <b>2004</b>. The lung <b>2004</b> is non-functional and fluid-filled. Instead, oxygenated blood is supplied to the fetus from gas-exchange in the placenta with the mother's blood supply. Specifically, oxygenated blood flows from the placenta, through the umbilical vein <b>2006</b> and into the right atrium <b>2022</b>. There, it flows via the foramen <b>2024</b> into the left atrium <b>2052</b>, where it is pumped into the left ventricle <b>2050</b> and then into the aortic trunk <b>2092</b>. Also, oxygenated blood is pumped from the right atrium <b>2022</b> into the right ventricle <b>2020</b> and directly into the descending aorta <b>2040</b> via the main pulmonary artery <b>2080</b> and the ductus arteriosus <b>2030</b>. Normally, the ductus arteriosus <b>2030</b> is only open (patent) during fetal life and the first 12 to 24 hours of life in term infants. The purpose of the ductus arteriosus <b>2030</b> is to shunt blood pumped by the right ventricle <b>2020</b> past the constricted pulmonary circulation <b>2010</b> and into the aorta <b>2040</b>.</p>
    <p num="p-0113"> <figref idrefs="DRAWINGS">FIG. 21</figref> illustrates a neonatal heart <b>2002</b> with a patent ductus arteriosus <b>2030</b>. The ductus arteriosus frequently fails to close in premature infants, allowing left-to-right shunting, i.e. oxygenated “red” blood flows from the aorta <b>2040</b> to the now unconstricted pulmonary artery <b>2010</b> and recirculates through the lungs <b>2004</b>. A persistent patent ductus arteriosus (PDA) results in pulmonary hyperperfusion and an enlarged right ventricle <b>2020</b>, which leads to a variety of abnormal respiratory, cardiac and genitourinary symptoms. Current PDA diagnosis involves physical examination, chest x-ray, blood gas analysis, echocardiogram, or a combination of the above. For example, large PDAs may be associated with a soft, long, low-frequency murmur detectable with a stethoscope. As another example, two-dimensional, color Doppler echocardiography may show a retrograde flow from the ductus arteriosus <b>2030</b> into the main pulmonary artery <b>2080</b>. Once a problematic PDA is detected, closure can be effected medically with indomethacin or ibuprofen or surgically by ligation. Multiple doses of indomethacin are commonplace but can still result in patency, demanding ligation. A drawback to current diagnostic techniques is that clinical symptoms of a PDA can vary on an hourly basis, requiring extended and inherently intermittent testing.</p>
    <p num="p-0114">The stereo pulse oximeter according to the present invention allows for continuous evaluation of PDA symptoms using non-invasive techniques. A right hand sensor <b>130</b> (<figref idrefs="DRAWINGS">FIG. 1</figref>) provides arterial oxygen saturation and a plethysmograph for blood circulating from the left ventricle <b>2050</b> through the innominate artery <b>2160</b>, which supplies the right subclavian artery leading to the right arm. Because the innominate artery <b>2160</b> is upstream from the shunt at the ductus arteriosus <b>2030</b>, the oxygen saturation value and plethysmograph waveform obtained from the right hand are relatively unaffected by the shunt and serve as a baseline for comparison with readings from other tissue sites.</p>
    <p num="p-0115">A foot sensor <b>120</b> (<figref idrefs="DRAWINGS">FIG. 1</figref>) provides oxygen status for blood supplied from the descending aorta <b>2040</b>. Unlike a PPHN condition, the shunt <b>2030</b> does not affect oxygen saturation in the descending aorta <b>2040</b>, because the relatively low pressure in the pulmonary artery <b>2010</b> does not allow a mixing of deoxygenated blood into the relatively high pressure flow of oxygenated blood in the aorta <b>2040</b>. However, like a PPHN condition, the shunt <b>2030</b> does affect the aortic flow. In particular, the shunt allows a transitory left-to-right flow during systole from the high pressure aorta <b>2040</b> to the low pressure pulmonary circulation <b>2010</b>. This left-to-right flow through the shunt <b>1930</b> alters the flow in the descending aorta <b>1940</b> and, as a result, the plethysmograph features measured at the foot. The PDA condition, therefore, is manifested as a normal plethysmograph with a characteristically narrow peak and well-defined dicrotic notch at the right-hand baseline site compared with a damped plethysmograph with a broadened peak and reduced or missing notch at the foot site. Further, the foot site waveform is phase shifted from the baseline waveform. These plethysmograph differences are accompanied by comparable arterial oxygen saturation values between the right-hand site and the foot site.</p>
    <p num="p-0116">An optional left hand sensor <b>110</b> (<figref idrefs="DRAWINGS">FIG. 1</figref>) provides oxygen status for blood circulating from the left ventricle through the left subclavian artery <b>2170</b> that supplies the left arm. Because the left subclavian artery <b>2170</b> is nearer the shunt <b>2030</b> than the further upstream innominate artery <b>2160</b>, it may experience some alteration in flow due to the shunt <b>2030</b>. The PDA condition, therefore, may also be manifested as an altered plethysmograph waveform at a left hand site as compared with the right hand baseline site, although to a lesser degree than with a foot site. Thus, the PDA condition can be detected and its treatment monitored from Δsat<sub>xy</sub>≈0 and plethysmograph morphology and phase comparisons between a right hand baseline sensor site and one or more other sites, such as the left hand or foot. One of ordinary skill will recognize that multiple site comparisons using the stereo pulse oximeter of the current invention may also be used to detect other cardiac abnormalities that cause mixing of oxygenated and deoxygenated blood, such as a ventricular hole or a patent foramen. Further, abnormal mixing of oxygenated and deoxygenated blood may also be manifested in measurements provided by the stereo oximeters other than Δsat<sub>xy </sub>and .Δpleth<sub>xy </sub>as described above. For example, an inversion in Δsat at a particular tissue site, i.e., Sp<sub>v</sub>O<sub>2 </sub>being larger than Sp<sub>a</sub>O<sub>2 </sub>at that site, would indicate such an abnormal condition.</p>
    <p num="p-0117">Aortic Coarctation</p>
    <p num="p-0118">Coarctation of the aorta is a congenital cardiac anomaly in which obstruction or narrowing occurs in the distal aortic arch or proximal descending aorta. It occurs as either an isolated lesion or coexisting with a variety of other congenital cardiac anomalies, such as a PDA. If the constriction is preductal, lower-trunk blood flow is supplied predominantly by the right ventricle via the ductus arteriosus, and cyanosis, i.e. poorly oxygenated blood, is present distal to the coarctation. This can be detected by the stereo pulse oximeter from a comparison of Sp<sub>a</sub>O<sub>2 </sub>between an upper body and a lower body site. If the constriction is postductal, blood supply to the lower trunk is supplied via the ascending aorta Differential plethysmographs between the upper and lower extremities may not exist if the ductus is widely patent. If the ductus closes, however, this condition can be detected by the stereo pulse oximeter as a reduced amplitude and phase delay between the plethysmographs measured at a lower body site with respect to an upper body site.</p>
    <p num="p-0119">The stereo pulse oximeter has been disclosed in detail in connection with various embodiments of the present invention. These embodiments are disclosed by way of examples only and are not to limit the scope of the present invention, which is defined by the claims that follow. One of ordinary skill in the art will appreciate many variations and modifications within the scope of this invention.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3704706">US3704706</a></td><td class="patent-data-table-td patent-date-value">Oct 23, 1969</td><td class="patent-data-table-td patent-date-value">Dec 5, 1972</td><td class="patent-data-table-td ">Univ Drexel</td><td class="patent-data-table-td ">Heart rate and respiratory monitor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3847483">US3847483</a></td><td class="patent-data-table-td patent-date-value">Sep 24, 1973</td><td class="patent-data-table-td patent-date-value">Nov 12, 1974</td><td class="patent-data-table-td ">D Lobdell</td><td class="patent-data-table-td ">Optical oximeter apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4109643">US4109643</a></td><td class="patent-data-table-td patent-date-value">Jun 17, 1976</td><td class="patent-data-table-td patent-date-value">Aug 29, 1978</td><td class="patent-data-table-td ">Hewlett-Packard Company</td><td class="patent-data-table-td ">Perfusion meter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4653498">US4653498</a></td><td class="patent-data-table-td patent-date-value">May 20, 1986</td><td class="patent-data-table-td patent-date-value">Mar 31, 1987</td><td class="patent-data-table-td ">Nellcor Incorporated</td><td class="patent-data-table-td ">Pulse oximeter monitor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4854699">US4854699</a></td><td class="patent-data-table-td patent-date-value">Nov 2, 1987</td><td class="patent-data-table-td patent-date-value">Aug 8, 1989</td><td class="patent-data-table-td ">Nippon Colin Co., Ltd.</td><td class="patent-data-table-td ">Blood oxygen saturation monitoring system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4869253">US4869253</a></td><td class="patent-data-table-td patent-date-value">Aug 18, 1986</td><td class="patent-data-table-td patent-date-value">Sep 26, 1989</td><td class="patent-data-table-td ">Physio-Control Corporation</td><td class="patent-data-table-td ">Method and apparatus for indicating perfusion and oxygen saturation trends in oximetry</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4911167">US4911167</a></td><td class="patent-data-table-td patent-date-value">Mar 30, 1988</td><td class="patent-data-table-td patent-date-value">Mar 27, 1990</td><td class="patent-data-table-td ">Nellcor Incorporated</td><td class="patent-data-table-td ">Method and apparatus for detecting optical pulses</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4927264">US4927264</a></td><td class="patent-data-table-td patent-date-value">Dec 1, 1988</td><td class="patent-data-table-td patent-date-value">May 22, 1990</td><td class="patent-data-table-td ">Omron Tateisi Electronics Co.</td><td class="patent-data-table-td ">Non-invasive measuring method and apparatus of blood constituents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4960128">US4960128</a></td><td class="patent-data-table-td patent-date-value">Nov 14, 1988</td><td class="patent-data-table-td patent-date-value">Oct 2, 1990</td><td class="patent-data-table-td ">Paramed Technology Incorporated</td><td class="patent-data-table-td ">Method and apparatus for continuously and non-invasively measuring the blood pressure of a patient</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4964408">US4964408</a></td><td class="patent-data-table-td patent-date-value">Apr 29, 1988</td><td class="patent-data-table-td patent-date-value">Oct 23, 1990</td><td class="patent-data-table-td ">Thor Technology Corporation</td><td class="patent-data-table-td ">Oximeter sensor assembly with integral cable</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5020516">US5020516</a></td><td class="patent-data-table-td patent-date-value">Mar 31, 1988</td><td class="patent-data-table-td patent-date-value">Jun 4, 1991</td><td class="patent-data-table-td ">Cardiopulmonary Corporation</td><td class="patent-data-table-td ">Improving the cardiac output</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5041187">US5041187</a></td><td class="patent-data-table-td patent-date-value">Oct 1, 1990</td><td class="patent-data-table-td patent-date-value">Aug 20, 1991</td><td class="patent-data-table-td ">Thor Technology Corporation</td><td class="patent-data-table-td ">Mounting light emitting and receiving components on a conductor covered with elongated, flexible dielectric film</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5069213">US5069213</a></td><td class="patent-data-table-td patent-date-value">Dec 19, 1989</td><td class="patent-data-table-td patent-date-value">Dec 3, 1991</td><td class="patent-data-table-td ">Thor Technology Corporation</td><td class="patent-data-table-td ">Oximeter sensor assembly with integral cable and encoder</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5078136">US5078136</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 1989</td><td class="patent-data-table-td patent-date-value">Jan 7, 1992</td><td class="patent-data-table-td ">Nellcor Incorporated</td><td class="patent-data-table-td ">Method and apparatus for calculating arterial oxygen saturation based plethysmographs including transients</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5163438">US5163438</a></td><td class="patent-data-table-td patent-date-value">Sep 24, 1990</td><td class="patent-data-table-td patent-date-value">Nov 17, 1992</td><td class="patent-data-table-td ">Paramed Technology Incorporated</td><td class="patent-data-table-td ">Method and apparatus for continuously and noninvasively measuring the blood pressure of a patient</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5218962">US5218962</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 15, 1991</td><td class="patent-data-table-td patent-date-value">Jun 15, 1993</td><td class="patent-data-table-td ">Nellcor Incorporated</td><td class="patent-data-table-td ">Multiple region pulse oximetry probe and oximeter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5251632">US5251632</a></td><td class="patent-data-table-td patent-date-value">Jul 9, 1991</td><td class="patent-data-table-td patent-date-value">Oct 12, 1993</td><td class="patent-data-table-td ">Hamamatsu Photonics K.K.</td><td class="patent-data-table-td ">Tissue oxygen measuring system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5253645">US5253645</a></td><td class="patent-data-table-td patent-date-value">Dec 13, 1991</td><td class="patent-data-table-td patent-date-value">Oct 19, 1993</td><td class="patent-data-table-td ">Critikon, Inc.</td><td class="patent-data-table-td ">Method of producing an audible alarm in a blood pressure and pulse oximeter monitor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5273036">US5273036</a></td><td class="patent-data-table-td patent-date-value">Apr 20, 1993</td><td class="patent-data-table-td patent-date-value">Dec 28, 1993</td><td class="patent-data-table-td ">Ppg Industries, Inc.</td><td class="patent-data-table-td ">Apparatus and method for monitoring respiration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5308919">US5308919</a></td><td class="patent-data-table-td patent-date-value">Apr 27, 1992</td><td class="patent-data-table-td patent-date-value">May 3, 1994</td><td class="patent-data-table-td ">Minnich Thomas E</td><td class="patent-data-table-td ">Method and apparatus for monitoring the arteriovenous oxygen difference from the ocular fundus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5337744">US5337744</a></td><td class="patent-data-table-td patent-date-value">Jul 14, 1993</td><td class="patent-data-table-td patent-date-value">Aug 16, 1994</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Low noise finger cot probe</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5385144">US5385144</a></td><td class="patent-data-table-td patent-date-value">Jul 21, 1993</td><td class="patent-data-table-td patent-date-value">Jan 31, 1995</td><td class="patent-data-table-td ">Minolta Co., Ltd.</td><td class="patent-data-table-td ">Respiration diagnosis apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5396893">US5396893</a></td><td class="patent-data-table-td patent-date-value">Feb 14, 1991</td><td class="patent-data-table-td patent-date-value">Mar 14, 1995</td><td class="patent-data-table-td ">Oberg; Ake P.</td><td class="patent-data-table-td ">Method and apparatus for analyzing heart and respiratory frequencies photoplethysmographically</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5431170">US5431170</a></td><td class="patent-data-table-td patent-date-value">May 28, 1991</td><td class="patent-data-table-td patent-date-value">Jul 11, 1995</td><td class="patent-data-table-td ">Mathews; Geoffrey R.</td><td class="patent-data-table-td ">For application to a body</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5452717">US5452717</a></td><td class="patent-data-table-td patent-date-value">Jun 2, 1994</td><td class="patent-data-table-td patent-date-value">Sep 26, 1995</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">For analyzing at least one characteristic of tissue</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5482036">US5482036</a></td><td class="patent-data-table-td patent-date-value">May 26, 1994</td><td class="patent-data-table-td patent-date-value">Jan 9, 1996</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5490505">US5490505</a></td><td class="patent-data-table-td patent-date-value">Oct 6, 1993</td><td class="patent-data-table-td patent-date-value">Feb 13, 1996</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5494043">US5494043</a></td><td class="patent-data-table-td patent-date-value">May 4, 1993</td><td class="patent-data-table-td patent-date-value">Feb 27, 1996</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Arterial sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5522388">US5522388</a></td><td class="patent-data-table-td patent-date-value">Sep 15, 1994</td><td class="patent-data-table-td patent-date-value">Jun 4, 1996</td><td class="patent-data-table-td ">Kowa Company Ltd.</td><td class="patent-data-table-td ">Pulse spectrometer</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5533511">US5533511</a></td><td class="patent-data-table-td patent-date-value">Jan 5, 1994</td><td class="patent-data-table-td patent-date-value">Jul 9, 1996</td><td class="patent-data-table-td ">Vital Insite, Incorporated</td><td class="patent-data-table-td ">Apparatus and method for noninvasive blood pressure measurement</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5542421">US5542421</a></td><td class="patent-data-table-td patent-date-value">Aug 30, 1994</td><td class="patent-data-table-td patent-date-value">Aug 6, 1996</td><td class="patent-data-table-td ">Frederick Erdman Association</td><td class="patent-data-table-td ">Method and apparatus for cardiovascular diagnosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5562002">US5562002</a></td><td class="patent-data-table-td patent-date-value">Feb 3, 1995</td><td class="patent-data-table-td patent-date-value">Oct 8, 1996</td><td class="patent-data-table-td ">Sensidyne Inc.</td><td class="patent-data-table-td ">Positive displacement piston flow meter with damping assembly</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5575284">US5575284</a></td><td class="patent-data-table-td patent-date-value">Apr 1, 1994</td><td class="patent-data-table-td patent-date-value">Nov 19, 1996</td><td class="patent-data-table-td ">University Of South Florida</td><td class="patent-data-table-td ">Diagnostic instrument for determining a parameter of a cardiovascular system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5590649">US5590649</a></td><td class="patent-data-table-td patent-date-value">Apr 15, 1994</td><td class="patent-data-table-td patent-date-value">Jan 7, 1997</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Apparatus and method for measuring an induced perturbation to determine blood pressure</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5602924">US5602924</a></td><td class="patent-data-table-td patent-date-value">Dec 9, 1993</td><td class="patent-data-table-td patent-date-value">Feb 11, 1997</td><td class="patent-data-table-td ">Theratechnologies Inc.</td><td class="patent-data-table-td ">Electronic stethescope</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5632272">US5632272</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 1994</td><td class="patent-data-table-td patent-date-value">May 27, 1997</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5638816">US5638816</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Jun 17, 1997</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Active pulse blood constituent monitoring</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5638818">US5638818</a></td><td class="patent-data-table-td patent-date-value">Nov 1, 1994</td><td class="patent-data-table-td patent-date-value">Jun 17, 1997</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Energy sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5645440">US5645440</a></td><td class="patent-data-table-td patent-date-value">Oct 16, 1995</td><td class="patent-data-table-td patent-date-value">Jul 8, 1997</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Patient cable connector</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5647359">US5647359</a></td><td class="patent-data-table-td patent-date-value">Mar 31, 1994</td><td class="patent-data-table-td patent-date-value">Jul 15, 1997</td><td class="patent-data-table-td ">Terumo Kabushiki Kaisha</td><td class="patent-data-table-td ">Measuring apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5682877">US5682877</a></td><td class="patent-data-table-td patent-date-value">Apr 15, 1994</td><td class="patent-data-table-td patent-date-value">Nov 4, 1997</td><td class="patent-data-table-td ">Mondry; Adolph J.</td><td class="patent-data-table-td ">System and method for automatically maintaining a blood oxygen saturation level</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5685299">US5685299</a></td><td class="patent-data-table-td patent-date-value">Dec 14, 1995</td><td class="patent-data-table-td patent-date-value">Nov 11, 1997</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5743261">US5743261</a></td><td class="patent-data-table-td patent-date-value">Mar 28, 1995</td><td class="patent-data-table-td patent-date-value">Apr 28, 1998</td><td class="patent-data-table-td ">Sensor Devices, Inc.</td><td class="patent-data-table-td ">Methods and apparatus for the invasive use of oximeter probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5743262">US5743262</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Apr 28, 1998</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Blood glucose monitoring system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5743857">US5743857</a></td><td class="patent-data-table-td patent-date-value">Jan 12, 1996</td><td class="patent-data-table-td patent-date-value">Apr 28, 1998</td><td class="patent-data-table-td ">Colin Corporation</td><td class="patent-data-table-td ">Blood pressure monitor apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5758644">US5758644</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Jun 2, 1998</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Manual and automatic probe calibration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5760910">US5760910</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Jun 2, 1998</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Optical filter for spectroscopic measurement and method of producing the optical filter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5769785">US5769785</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1995</td><td class="patent-data-table-td patent-date-value">Jun 23, 1998</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5782757">US5782757</a></td><td class="patent-data-table-td patent-date-value">Oct 16, 1995</td><td class="patent-data-table-td patent-date-value">Jul 21, 1998</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">For non-invasive measurement of characteristics of a medium</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5785659">US5785659</a></td><td class="patent-data-table-td patent-date-value">May 17, 1996</td><td class="patent-data-table-td patent-date-value">Jul 28, 1998</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Monitor for indicating a change in a patient&#39;s blood pressure</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5791347">US5791347</a></td><td class="patent-data-table-td patent-date-value">Aug 14, 1996</td><td class="patent-data-table-td patent-date-value">Aug 11, 1998</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Motion insensitive pulse detector</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5810734">US5810734</a></td><td class="patent-data-table-td patent-date-value">Nov 22, 1995</td><td class="patent-data-table-td patent-date-value">Sep 22, 1998</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Monitor for determining a physiological parameter of a patient</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5823950">US5823950</a></td><td class="patent-data-table-td patent-date-value">Nov 12, 1996</td><td class="patent-data-table-td patent-date-value">Oct 20, 1998</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Manual and automatic probe calibration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5827181">US5827181</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 1997</td><td class="patent-data-table-td patent-date-value">Oct 27, 1998</td><td class="patent-data-table-td ">Hewlett-Packard Co.</td><td class="patent-data-table-td ">Noninvasive blood chemistry measurement method and system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5830131">US5830131</a></td><td class="patent-data-table-td patent-date-value">Nov 22, 1995</td><td class="patent-data-table-td patent-date-value">Nov 3, 1998</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Apparatus and method for measuring an induced perturbation to determine a physical condition of the human arterial system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5830135">US5830135</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 31, 1994</td><td class="patent-data-table-td patent-date-value">Nov 3, 1998</td><td class="patent-data-table-td ">Bosque; Elena M.</td><td class="patent-data-table-td ">Fuzzy logic alarm system for pulse oximeters</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5833618">US5833618</a></td><td class="patent-data-table-td patent-date-value">Nov 22, 1995</td><td class="patent-data-table-td patent-date-value">Nov 10, 1998</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Apparatus and method for measuring an induced perturbation to determine a physiological parameter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5846190">US5846190</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 10, 1996</td><td class="patent-data-table-td patent-date-value">Dec 8, 1998</td><td class="patent-data-table-td ">Hewlett-Packard Company</td><td class="patent-data-table-td ">Method of and apparatus for recognizing falsified pulse oximetry measurements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5860919">US5860919</a></td><td class="patent-data-table-td patent-date-value">Apr 17, 1997</td><td class="patent-data-table-td patent-date-value">Jan 19, 1999</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">For varying an attenuation of optical radiation due to fluid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5890929">US5890929</a></td><td class="patent-data-table-td patent-date-value">Jun 3, 1997</td><td class="patent-data-table-td patent-date-value">Apr 6, 1999</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Shielded medical connector</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5904654">US5904654</a></td><td class="patent-data-table-td patent-date-value">Feb 26, 1996</td><td class="patent-data-table-td patent-date-value">May 18, 1999</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Exciter-detector unit for measuring physiological parameters</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5919134">US5919134</a></td><td class="patent-data-table-td patent-date-value">Jan 12, 1998</td><td class="patent-data-table-td patent-date-value">Jul 6, 1999</td><td class="patent-data-table-td ">Masimo Corp.</td><td class="patent-data-table-td ">Method and apparatus for demodulating signals in a pulse oximetry system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5934925">US5934925</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 1997</td><td class="patent-data-table-td patent-date-value">Aug 10, 1999</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Patient cable connector</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5940182">US5940182</a></td><td class="patent-data-table-td patent-date-value">Jun 1, 1998</td><td class="patent-data-table-td patent-date-value">Aug 17, 1999</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Optical filter for spectroscopic measurement and method of producing the optical filter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5954053">US5954053</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 1995</td><td class="patent-data-table-td patent-date-value">Sep 21, 1999</td><td class="patent-data-table-td ">Non-Invasive Technology, Inc.</td><td class="patent-data-table-td ">Detection of brain hematoma</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5995855">US5995855</a></td><td class="patent-data-table-td patent-date-value">Feb 11, 1998</td><td class="patent-data-table-td patent-date-value">Nov 30, 1999</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Pulse oximetry sensor adapter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5997343">US5997343</a></td><td class="patent-data-table-td patent-date-value">Mar 19, 1998</td><td class="patent-data-table-td patent-date-value">Dec 7, 1999</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Patient cable sensor switch</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6002952">US6002952</a></td><td class="patent-data-table-td patent-date-value">Apr 14, 1997</td><td class="patent-data-table-td patent-date-value">Dec 14, 1999</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6011986">US6011986</a></td><td class="patent-data-table-td patent-date-value">Feb 2, 1998</td><td class="patent-data-table-td patent-date-value">Jan 4, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Manual and automatic probe calibration</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6027452">US6027452</a></td><td class="patent-data-table-td patent-date-value">Jun 26, 1996</td><td class="patent-data-table-td patent-date-value">Feb 22, 2000</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Rapid non-invasive blood pressure measuring device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6036642">US6036642</a></td><td class="patent-data-table-td patent-date-value">Jun 22, 1998</td><td class="patent-data-table-td patent-date-value">Mar 14, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6045509">US6045509</a></td><td class="patent-data-table-td patent-date-value">Feb 19, 1998</td><td class="patent-data-table-td patent-date-value">Apr 4, 2000</td><td class="patent-data-table-td ">Vital Insite, Inc.</td><td class="patent-data-table-td ">Apparatus and method for measuring an induced perturbation to determine a physiological parameter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6067462">US6067462</a></td><td class="patent-data-table-td patent-date-value">May 19, 1998</td><td class="patent-data-table-td patent-date-value">May 23, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6081735">US6081735</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 1997</td><td class="patent-data-table-td patent-date-value">Jun 27, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6088607">US6088607</a></td><td class="patent-data-table-td patent-date-value">Jan 28, 1997</td><td class="patent-data-table-td patent-date-value">Jul 11, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Low noise optical probe</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6094592">US6094592</a></td><td class="patent-data-table-td patent-date-value">May 26, 1998</td><td class="patent-data-table-td patent-date-value">Jul 25, 2000</td><td class="patent-data-table-td ">Nellcor Puritan Bennett, Inc.</td><td class="patent-data-table-td ">Methods and apparatus for estimating a physiological parameter using transforms</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6110522">US6110522</a></td><td class="patent-data-table-td patent-date-value">Apr 16, 1998</td><td class="patent-data-table-td patent-date-value">Aug 29, 2000</td><td class="patent-data-table-td ">Masimo Laboratories</td><td class="patent-data-table-td ">Blood glucose monitoring system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6122535">US6122535</a></td><td class="patent-data-table-td patent-date-value">Mar 10, 1998</td><td class="patent-data-table-td patent-date-value">Sep 19, 2000</td><td class="patent-data-table-td ">Hewlett-Packard Company</td><td class="patent-data-table-td ">Method and apparatus for determining the concentration of a component</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6144868">US6144868</a></td><td class="patent-data-table-td patent-date-value">Apr 12, 1999</td><td class="patent-data-table-td patent-date-value">Nov 7, 2000</td><td class="patent-data-table-td ">Sensidyne, Inc.</td><td class="patent-data-table-td ">Reusable pulse oximeter probe and disposable bandage apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6151516">US6151516</a></td><td class="patent-data-table-td patent-date-value">Nov 12, 1998</td><td class="patent-data-table-td patent-date-value">Nov 21, 2000</td><td class="patent-data-table-td ">Masimo Laboratories</td><td class="patent-data-table-td ">Active pulse blood constituent monitoring</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6152754">US6152754</a></td><td class="patent-data-table-td patent-date-value">Dec 21, 1999</td><td class="patent-data-table-td patent-date-value">Nov 28, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Circuit board based cable connector</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6157850">US6157850</a></td><td class="patent-data-table-td patent-date-value">May 16, 1997</td><td class="patent-data-table-td patent-date-value">Dec 5, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6165005">US6165005</a></td><td class="patent-data-table-td patent-date-value">Dec 7, 1999</td><td class="patent-data-table-td patent-date-value">Dec 26, 2000</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Patient cable sensor switch</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6184521">US6184521</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 1998</td><td class="patent-data-table-td patent-date-value">Feb 6, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Photodiode detector with integrated noise shielding</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6206830">US6206830</a></td><td class="patent-data-table-td patent-date-value">Nov 17, 1999</td><td class="patent-data-table-td patent-date-value">Mar 27, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6229856">US6229856</a></td><td class="patent-data-table-td patent-date-value">Apr 10, 1998</td><td class="patent-data-table-td patent-date-value">May 8, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Method and apparatus for demodulating signals in a pulse oximetry system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6236872">US6236872</a></td><td class="patent-data-table-td patent-date-value">Nov 25, 1998</td><td class="patent-data-table-td patent-date-value">May 22, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6256523">US6256523</a></td><td class="patent-data-table-td patent-date-value">Jun 9, 1998</td><td class="patent-data-table-td patent-date-value">Jul 3, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Low-noise optical probes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6263222">US6263222</a></td><td class="patent-data-table-td patent-date-value">Oct 6, 1997</td><td class="patent-data-table-td patent-date-value">Jul 17, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Signal processing apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6278522">US6278522</a></td><td class="patent-data-table-td patent-date-value">May 26, 1999</td><td class="patent-data-table-td patent-date-value">Aug 21, 2001</td><td class="patent-data-table-td ">Masimo Laboratories</td><td class="patent-data-table-td ">Optical filter for spectroscopic measurement and method of producing the optical filter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6280213">US6280213</a></td><td class="patent-data-table-td patent-date-value">Nov 7, 2000</td><td class="patent-data-table-td patent-date-value">Aug 28, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Patient cable connector</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6285896">US6285896</a></td><td class="patent-data-table-td patent-date-value">Jul 7, 1999</td><td class="patent-data-table-td patent-date-value">Sep 4, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Fetal pulse oximetry sensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6321100">US6321100</a></td><td class="patent-data-table-td patent-date-value">Jul 13, 1999</td><td class="patent-data-table-td patent-date-value">Nov 20, 2001</td><td class="patent-data-table-td ">Sensidyne, Inc.</td><td class="patent-data-table-td ">Reusable pulse oximeter probe with disposable liner</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6334065">US6334065</a></td><td class="patent-data-table-td patent-date-value">May 27, 1999</td><td class="patent-data-table-td patent-date-value">Dec 25, 2001</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Stereo pulse oximeter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6343224">US6343224</a></td><td class="patent-data-table-td patent-date-value">Oct 14, 1999</td><td class="patent-data-table-td patent-date-value">Jan 29, 2002</td><td class="patent-data-table-td ">Sensidyne, Inc.</td><td class="patent-data-table-td ">Reusable pulse oximeter probe and disposable bandage apparatus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6349228">US6349228</a></td><td class="patent-data-table-td patent-date-value">Sep 23, 1999</td><td class="patent-data-table-td patent-date-value">Feb 19, 2002</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Pulse oximetry sensor adapter</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USD353195">USD353195</a></td><td class="patent-data-table-td patent-date-value">May 28, 1993</td><td class="patent-data-table-td patent-date-value">Dec 6, 1994</td><td class="patent-data-table-td "> </td><td class="patent-data-table-td ">Electronic stethoscope housing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USD353196">USD353196</a></td><td class="patent-data-table-td patent-date-value">May 28, 1993</td><td class="patent-data-table-td patent-date-value">Dec 6, 1994</td><td class="patent-data-table-td "> </td><td class="patent-data-table-td ">Stethoscope head</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USD361840">USD361840</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 1994</td><td class="patent-data-table-td patent-date-value">Aug 29, 1995</td><td class="patent-data-table-td "> </td><td class="patent-data-table-td ">Stethoscope head</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USD362063">USD362063</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 1994</td><td class="patent-data-table-td patent-date-value">Sep 5, 1995</td><td class="patent-data-table-td "> </td><td class="patent-data-table-td ">Stethoscope headset</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USD363120">USD363120</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 1994</td><td class="patent-data-table-td patent-date-value">Oct 10, 1995</td><td class="patent-data-table-td "> </td><td class="patent-data-table-td ">Stethoscope ear tip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USD393830">USD393830</a></td><td class="patent-data-table-td patent-date-value">Oct 16, 1995</td><td class="patent-data-table-td patent-date-value">Apr 28, 1998</td><td class="patent-data-table-td ">Masimo Corporation</td><td class="patent-data-table-td ">Patient cable connector</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bartlett, "<a href='http://scholar.google.com/scholar?q="Oxygen+Kinetics"'>Oxygen Kinetics</a>", Critical Care Physiology, 13th Ed., pp. 1-23.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Drummond, Willa H., "<a href='http://scholar.google.com/scholar?q="Ductus+Arteriosus"'>Ductus Arteriosus</a>", Cardiovascular Disease in the Neonate, pp. 760-771.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Dudell, Glode, et al., "<a href='http://scholar.google.com/scholar?q="What+Constitutes+Adequate+Oxygenation%3F"'>What Constitutes Adequate Oxygenation?</a>" Pediatrics, Jan. 1990, pp. 39-41.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Mallinckrodt inc. v. Masimo Corp., 2004 U.S. Dist. Lexis 28518 (C.D. Cal. Jul. 12, 2004).</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Mallinckrodt, Inc. v. Masimo Corp., 147 Fed. Appx. 158, 2005 WL 2139867 (Fed. Cir. 2005).</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-000080(JJF)) Complaint for Patent Infringement dated Feb. 3, 2009, pp. 1-13.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Defendant/Counterclaim-Plaintiff Philips Electronics North America Corporation Answer to Masimo's Counterclaims dated Aug. 3, 2009, pp. 1-23.</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Defendants'<a href='http://scholar.google.com/scholar?q="+Answer+and+Philips+Electronics+North+America+Corporation%27s+Amended+Counterclaims+to+Masimo"'> Answer and Philips Electronics North America Corporation's Amended Counterclaims to Masimo</a>'s First Amended Complaint, dated Apr. 21, 2010, pp. 1-62.</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Defendants'<a href='http://scholar.google.com/scholar?q="+Answer+and+Philips+Electronics+North+America+Corporation%27s+Counterclaims+to+Masimo"'> Answer and Philips Electronics North America Corporation's Counterclaims to Masimo</a>'s First Amended Complaint dated Jun. 15, 2009, pp. 1-65.</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) First Amended Complaint for Patent Infringement dated May 12, 2009, pp. 1-16.</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Masimo's Answer to Philips' Amended Counterclaims, dated May 10, 2010, pp. 1-76.</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Masimo's Answer to Philips' Counterclaims dated Jul. 9, 2009, pp. 1-68.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Philips Electronics North America Corporation's Answer to Masimo's Amended Counterclaims (D.I. 102) dated May 27, 2010, pp. 1-24.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Masimo Corporation v. Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH, (District of Delaware, Case No. 09-00080(JJF)) Philips North America Corporation and Philips Medizin Systeme Boblingen GmbH's Seventh Supplemental Objections and Responses to Masimo Corporation's First Set of Interrogatories (Nos. 1-8) dated Jun. 30, 2010, pp. 1-40 (redacted).</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Murray, Willie et al., "<a href='http://scholar.google.com/scholar?q="The+Peripheral+Pulse+Wave%3A+Information+Overlooked"'>The Peripheral Pulse Wave: Information Overlooked</a>", Journal of Clinical Monitoring, vol. 12, pp. 365-377, Sep. 1996.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Neuhof, H. et al., "<a href='http://scholar.google.com/scholar?q="Simultaneous+Continuous+Measurement+of+Arterial+and+Mixed+Venous+Partial+O2+Saturation"'>Simultaneous Continuous Measurement of Arterial and Mixed Venous Partial O2 Saturation</a>", The Oxygen Status of Arterial Blood, Zander, Mertzlufft (eds.), pp. 273-278 (Karger, Basel 1991).</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Scharf, University of South Florida Department of Anesthesiology, "<a href='http://scholar.google.com/scholar?q="Pulse+Oximetry+Through+Spectral+Analysis%2C"'>Pulse Oximetry Through Spectral Analysis,</a>" pp. 227-235.</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Scharf, USF Department of Anesthesiology, USF Department of Electrical Engineering, Optimization of Portable Pulse Oximetry Through Fourier Analysis, pp. 233-235.</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Steinke, John M., Comparison of Mie Theory and the Light Scattering of Red Blood Cells:, Applied Optics, vol. 27, No. 19, Oct. 1, 1998, pp. 4027-4033.</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Vjayakumar, E., et al., "<a href='http://scholar.google.com/scholar?q="Pulse+Oximetry+in+Infants+of+%26lt%3B1500+gm+Birth+Weight+on+Supplemental+Oxygen%3A+A+national+Survey"'>Pulse Oximetry in Infants of &lt;1500 gm Birth Weight on Supplemental Oxygen: A national Survey</a>", Journal of Perinatology, vol. 17, No. 5, 1997, pp. 341-345.</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Weis, Carla M. et al., "<a href='http://scholar.google.com/scholar?q="Oxygen+Therapy"'>Oxygen Therapy</a>", Chapt. 46, Pulmonary Disease in the Neonate, pp. 538-545.</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">White, Katherine, "<a href='http://scholar.google.com/scholar?q="Completing+the+Hemodynamic+Picture%3A+Svox"'>Completing the Hemodynamic Picture: Svox</a>", Heart &amp; Lung, May 1985, vol. 14, No. 3.</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wolf, Martin, et al., "<a href='http://scholar.google.com/scholar?q="Continuous+Noninvasive+Measurement+of+Cerebral+Arterial+and+Venous+Oxygen+Saturation+at+the+Bedside+in+Mechanically+Ventilated+Noenates%5C"'>Continuous Noninvasive Measurement of Cerebral Arterial and Venous Oxygen Saturation at the Bedside in Mechanically Ventilated Noenates\</a>", Critl Care Med, 1997, vol. 25, No. 9, pp. 1579-1582.</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8515513">US8515513</a></td><td class="patent-data-table-td patent-date-value">Oct 30, 2009</td><td class="patent-data-table-td patent-date-value">Aug 20, 2013</td><td class="patent-data-table-td ">Covidien Lp</td><td class="patent-data-table-td ">System and method for facilitating observation of monitored physiologic data</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8755871">US8755871</a></td><td class="patent-data-table-td patent-date-value">Nov 30, 2011</td><td class="patent-data-table-td patent-date-value">Jun 17, 2014</td><td class="patent-data-table-td ">Covidien Lp</td><td class="patent-data-table-td ">Systems and methods for detecting arrhythmia from a physiological signal</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc600/defs600.htm&usg=AFQjCNGoRRWCr3AADgOfjOLv9kXGux4XKA#C600S323000">600/323</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc600/defs600.htm&usg=AFQjCNGoRRWCr3AADgOfjOLv9kXGux4XKA#C600S340000">600/340</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0005145500">A61B5/1455</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61M0016000000">A61M16/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0005000000">A61B5/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0005145000">A61B5/145</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61B0005024000">A61B5/024</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/14551">A61B5/14551</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/0205">A61B5/0205</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/1459">A61B5/1459</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61M16/00">A61M16/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/6826">A61B5/6826</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/6815">A61B5/6815</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/746">A61B5/746</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/02416">A61B5/02416</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/6814">A61B5/6814</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61M2230/205">A61M2230/205</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/6838">A61B5/6838</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/6829">A61B5/6829</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/6825">A61B5/6825</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/742">A61B5/742</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=ZqovBwABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61B5/6819">A61B5/6819</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61B5/68B3L</span>, <span class="nested-value">A61B5/68B2J1</span>, <span class="nested-value">A61B5/68B2N</span>, <span class="nested-value">A61B5/1455N</span>, <span class="nested-value">A61B5/68B2J</span>, <span class="nested-value">A61B5/68B2B</span>, <span class="nested-value">A61B5/68B2B1</span>, <span class="nested-value">A61B5/68B2B4</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">May 27, 2014</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, ILLINOI</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20140423</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 032784 FRAME: 0864. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT;ASSIGNORS:MASIMO AMERICAS, INC.;MASIMO CORPORATION;REEL/FRAME:033032/0426</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 29, 2014</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MASIMO CORPORATION;MASIMO AMERICAS, INC.;REEL/FRAME:032784/0864</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20140423</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, ILLINOI</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 11, 2012</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120914</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 16, 2012</td><td class="patent-data-table-td ">CC</td><td class="patent-data-table-td ">Certificate of correction</td><td class="patent-data-table-td "></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U12wtipS9yR5JeMLq3akfs4_B_74Q\u0026id=ZqovBwABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2L1WpbMWESt70R-t3iOmicaKujzw\u0026id=ZqovBwABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U0z-EiiR2e5dddJXqE24cNuFbAVmw","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Physiological_monitor.pdf?id=ZqovBwABERAJ\u0026output=pdf\u0026sig=ACfU3U2ZxVu-TKw-NKsm2a2QPpGJuaDXmw"},"sample_url":"http://www.google.com/patents/reader?id=ZqovBwABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>